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PARTICLE CAPTURE DEVICES AND 	 such pairs. A device and methods are needed for high yield 
METHODS OF USE THEREOF 	 reactions between particle/cell pairs and for the controlled 
release and collection of the final product or modified cells. 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
	 5 	 SUMMARY OF THE INVENTION 
This application is a National Phase Application of PCT 
International Application No. PCT/US09/33785, Interna-
tional Filing Date Feb. 11, 2009, claiming priority of U.S. 
Provisional Patent Applications, 61/064,008, filed Feb. 11, 
2008, all of which are incorporated herein by reference in 
their entirety. 
GOVERNMENT INTEREST STATEMENT 
This invention was made with government support under 
grant number NAS7-1407 awarded by NASA, and grant 
numbers ROI EB007278 and 5-R37-CA084198 WIBR 
awarded by the National Institutes of Health. The government 
has certain rights in this invention. 
FIELD OF THE INVENTION 
This invention provides devices and methods of use thereof 
in particle capturing and particle pairing. 
BACKGROUND OF THE INVENTION 
Systematic investigation and understanding of small par-
ticles and biological cells depends on the tools available with 
which to probe particle or cell function. An important aspect 
of cell function is the interaction between two cells. Such 
interaction occurs at the interface and requires close contact 
between the two cells. Interaction between cells involves 
signaling, exchange of membrane material, exchange of 
intracellular material and fusion of the cells. For particles 
other than cells, interfacial interaction can result in chemical 
bonding of two particles and in chemical reactions between 
two particles. Currently, an ability to capture and pair par-
ticles in isolated, defined positions and with high yield is 
lacking. 
The main methods for particle/cell capturing and pairing 
involve the manipulation of one pair at a time. Usually, one 
particle/cell is held by one syringe/pipette, and is brought into 
contact with another cell held at the tip of a second syringe 
under a microscope. Alternately, one cell can be immobilized 
on a surface and the other cell will be brought into contact 
with it using a syringe. Optical trapping of one cell/particle in 
solution enables the controlled transfer of such cell into con-
tact with another cell that is held by a syringe, an immobiliz-
ing surface or an additional optical tweezers. Another method 
relies on the growth of two neighboring cells until they reach 
each other and become contacted on a surface. 
Large populations of cells/particles can be mixed in solu-
tion and get into contact. Solution conditions such as concen-
tration and temperature can enhance such interfacial contact 
between cells. Chemical functions on cell membranes and on 
particle surface can cause the binding of cells in solution. 
However, such binding/contact might be temporary, is not 
selective, the location of the pairs is not defined and the pairs 
are not isolated for further analysis. 
A device and methods are needed for the specific capturing 
and pairing of two cell s/particles, in predetermined positions, 
such that the two particles forming a pair are isolated from 
other pairs, immobilized, their surfaces are in close contact 
and the identity of each particle is controlled. A device and 
methods are needed for the observation and manipulation of 
The invention provides, in one embodiment, a particle 
capture or particle patterning device, the device comprising: 
a first substrate; 
10 	 at least one capture unit positioned such that the top of said 
capture unit is adhered to or contiguous with said first 
substrate, said capture unit comprising: 
a first chamber comprising at least one opening, sized to 
trap and accommodate a single particle; and 
i5 
a second chamber comprising at least one opening, sized 
to trap and accommodate a single or more than a 
single particle; 
wherein an opening of said first chamber faces a direction 
20 opposite to that of an opening of said second chamber, and 
said opening of said first chamber is contiguous with a side of 
said capture unit, said opening of said second chamber is 
contiguous with an opposite side of said capture unit; 
optionally a second substrate positioned proximally to or 
25 	 adhered to a bottom of said capture unit or a portion 
thereof, 
a conduit through which first flow may be induced in said 
device, such that fluid flow is accommodated at least 
between said capture unit and said second substrate and 
30 	 particles positioned within said first or second chamber 
are subject to said fluid flow; and 
optionally, a second conduit through which a second flow 
may be induced in a direction opposite to that of said first 
flow. 
35 	 In one embodiment, the device further comprises at least 
one supporting structure positioned between the first and 
second substrate, which aids in suspending the capture unit 
over the second substrate, at a height sufficient to accommo-
date fluid flow between the second substrate and the capture 
40 unit. 
In one embodiment, at least one supporting structure is 
proximal to or contiguous with at least a portion of the capture 
unit. 
In one embodiment, the first chamber, second chamber, or 
45 a combination thereof comprise at least one additional open-
ing, which is sized such that the opening cannot trap or 
accommodate one or more particles. 
In one embodiment, the additional opening is positioned 
between the first and second chamber such that the opening 
50 facilitates fluid communication between the first and second 
chamber. 
In one embodiment, the particle capturing device further 
comprises controllers to maintain desirable environmental 
conditions. 
55 	 In one embodiment, the controllers maintain a desired 
temperature, pH, CO 2 or oxygen conditions, or a combination 
thereof. 
In one embodiment, the particle capturing device is com-
prised of a transparent material. 
60 	 In one embodiment, the transparent material is pyrex, 
quartz, Polydimethylsiloxane (PDMS) or SU-8. 
In one embodiment, the particle patterning device further 
comprises electric connections between said first capture 
unit, said second capture unit or a combination thereof and a 
65 power supply. 
In one embodiment, the particle patterning device is a 
microfluidic device. 





In one embodiment, the first chamber has a width ranging 	 (ii) applying a second liquid to said device under flow in a 
	
from between 5-500 µm and a depth ranging from between 	 second direction, wherein said individual particle moves 
5-500 M. 	 from said first chamber of said first capture unit to a second 
	
In one embodiment, the first chamber has a width of about 	 chamber in a second capture unit. 
10 µm and a depth of about 5 µm. 	 5 	 In one embodiment, the method further comprising the step 
	
In one embodiment, the second chamber has a width rang- 	 of applying a third liquid comprising a series of second par- 
	
ing from between 5-500 µm and a depth ranging from 	 ticles to the device under flow, in the second direction, 
between 5-500 µm. 	 whereby the series of second particles are captured in the 
	
In one embodiment, the second chamber has a width of 	 second capture units with the series of the first particles. 
about 10 µm to about 35 µm and a depth of about 5.5 µm to 10 In one embodiment, the method further comprises the step 
about 50 µm. 	 of applying a third liquid to the device under flow in the first 
	
In one embodiment, the device comprises an array of cap- 	 direction, whereby the individual particle moves back to the 
	
ture units, which in one embodiment are positioned in a row 	 first chamber in the first capture unit. 
	
or column scheme, or a combination thereof. In one embodi- 	 In one embodiment, the series of first particles, second 
ment, the rows, columns or combinations thereof have a spac-  15 particles or a combination thereof are cells, vesicles, or 
	
ing there-between approximate in width to a diameter of a 	 microspheres or a combination thereof. 
	
particle being applied to the particle patterning device. In one 	 In one embodiment, the cells are mammalian cells, bacte- 
	
embodiment, capture units are positioned asymmetrically 	 rial cells, parasitic cells, yeast cells or a combination thereof. 
	
such that a first unit is off-set from that of a second capture 	 In one embodiment, the series of first particles and the 
unit in a preceding or subsequent row. In one embodiment, the 20 series of second particles comprise cells of a similar cell type 
	
off-set is half the center-to-center distance between two cap- 	 or are of, or isolated from, the same organism. 
turing units. 	 In one embodiment, the series of first particles and the 
	
In one embodiment, the invention provides an apparatus 	 series of second particles comprise cells of a different cell 
comprising the particle patterning device. 	 type or are of, or isolated from, a different organism. 
	
In one embodiment, the apparatus comprises an illumina-  25 	 In one embodiment, the cells comprise a vector, which 
tion source coupled to the device. 	 optionally comprises a reporter. 
In one embodiment, the illumination source is a laser. 	 In one embodiment, the method is a fusion method 
	
In one embodiment, a beam splitter is employed with the 	 between the cells, vesicles or microspheres or a combination 
use of the illumination source. 	 thereof. 
In one embodiment, the apparatus further comprises a 30 In one embodiment, the method further comprises apply- 
	
detector, which detects a change in a parameter in the device. 	 ing a reagent to the device under flow in the second direction. 
	
In one embodiment, the detector comprises a camera, a 	 In one embodiment, the reagent is for detection, assay or a 
	
computer, a luminometer, a spectrophotometer or a combina- 	 combination thereof of the series of first particles, second 
tion thereof. 	 particles or a combination thereof. 
The invention provides, in one embodiment, a method for 35 In one embodiment, the reagent comprises a detectable 
patterning individual particles, the method comprising: 	 marker. 
	
(i) applying a first liquid comprising a series of first par- 	 In one embodiment, the series of first particles and the 
	
ticles to a particle patterning device under flow in a first 	 series of second particles are of the same size. 
direction, whereby an individual particle is accommodated In one embodiment, the series of first particles and the 
within a first chamber in a first capture unit of said particle 40 series of second particles differ in size, composition or a 
patterning device, said device comprising: combination thereof. 
a first substrate; 	 In one embodiment, the method further comprises the step 
	
at least one capture unit positioned such that the top of said 	 of observing the series of first particles over a course of time. 
	
capture unit is adhered to or contiguous with said first 	 In one embodiment, the device is maintained under con- 
substrate, said capture unit comprising: 	 45 trolled temperature, pH, CO 2, or oxygen conditions, or a 
	
a first chamber comprising at least one opening, sized to 	 combination thereof for the course of time in which the par- 
trap and accommodate a single particle; and 	 ticles are being observed. 
	
a second chamber comprising at least one opening, sized 
	
In one embodiment, this invention provides a method of 
	
to trap and accommodate a single or more than a 	 contacting individual particles, said method comprising: 
single particle; 	 50 	 (i) applying a first liquid comprising a series of first par- 
	
wherein an opening of said first chamber faces a direc- 	 ticles to a particle patterning device under flow in a first 
	
tion opposite to that of an opening of said second 
	
direction, whereby an individual particle is accommodated 
	
chamber, and said opening of said first chamber is 	 within a first capture unit of said particle patterning device, 
	
contiguous with a side of said capture unit, said open- 	 said device comprising: 
	
ing of said second chamber is contiguous with an 55 	 a first substrate; 
opposite side of said capture unit; 	 at least one capture unit positioned such that the top of said 
	
optionally a second substrate positioned proximally to or 	 capture unit is adhered to or contiguous with said first 
	
adhered to a bottom of said capture unit or a portion 	 substrate, said capture unit comprising: 
thereof, 	 a first chamber comprising at least one opening, sized to 
	
a conduit through which first flow may be induced in said 60 	 trap and accommodate a single particle; and 
	
device, such that fluid flow is accommodated at least 	 a second chamber comprising at least one opening, sized 
	
between said capture unit and said second substrate and 	 to trap and accommodate a single or more than a 
	
particles positioned within said first or second chamber 	 single particle; 
are subject to said fluid flow; and 	 wherein an opening of said first chamber faces a direc- 
	
optionally, a second conduit through which a second flow 65 	 tion opposite to that of an opening of said second 
	
maybe induced in a direction opposite to that of said first 	 chamber, and said opening of said first chamber is 
flow; and 	 contiguous with a side of said capture unit, said open- 
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ing of said second chamber is contiguous with an 
opposite side of said capture unit; 
optionally a second substrate positioned proximally to or 
adhered to a bottom of said capture unit or a portion 
thereof, 5 
a conduit through which first flow may be induced in said 
device, such that fluid flow is accommodated at least 
between said capture unit and said second substrate and 
particles positioned within said first or second chamber 
are subject to said fluid flow; and 10 
optionally, a second conduit through which a second flow 
maybe induced in a direction opposite to that of said first 
flow; and 
(ii) applying flow in a second direction, wherein said indi- 
vidual particle moves from said first chamber of said first 15 
capture unit to a second chamber in a second capture unit; and 
(iii) applying a second liquid comprising a series of second 
particles to said device in said second direction, 
whereby said second particles positioned within said sec-
ond chamber are brought into contact with said series of first 20 
particles, thereby being a method of contacting individual 
particles. 
In one embodiment, bringing the first and second series of 
particles into contact results in a transfer of materials from 
one particle to another. In one embodiment, the materials 25 
comprise a biological material, which in one embodiment is a 
nucleic acid or polypeptide. 
In one embodiment, the particle is a cell, and in another 
embodiment, the method results in genetic transformation of 
said cell. In one embodiment, the first or second series of 30 
particles or a combination thereof are cells, and in one 
embodiment, the method comprises a method of cell fusion. 
In one embodiment, the method comprises a method of 
single cell infection and in another embodiment the method 
comprises a method of phagocytosis. 35 
In one embodiment, bringing the first and second series of 
particles into contact results in a measurable energy transfer, 
which in one embodiment is fluorescent resonance energy 
transfer (FRET). 
In another embodiment, the method comprises a screen for 40 
molecular interactions. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG.1 schematically depicts an embodiment of a device of 45 
this invention. SEM images of the capture device are shown. 
Each capture unit consists of front and back chambers. Sup-
port pillars maintain proper spacing of the chambers from the 
surface of the second substrate. 
FIG. 2 schematically depicts an embodiment of a method 50 
of this invention. A schematic of a two-cell loading process is 
illustrated on the left. On the right, fluorescent microscopy 
images are shown for the two-cell capturing and pairing pro-
cess. Three steps are presented top to bottom: (1) Loading of 
cells type 1 in a direction where fluid flow opposes the open-  55 
ing of the first, smaller chambers, so cells from the fluid can 
be trapped in the first, smaller capture units; (2) Reversing of 
the fluid flow direction such that the cells type 1 exit the first, 
small capture units and enter the opposing second, larger 
capture units. (3) Introduction of cells type 2 with the same 60 
fluid direction, such that cells type 2 can enter the second, 
larger capture units and join cells type 1 (green) that are 
already trapped in it. 
FIG. 3 is a fluorescent overlay image of one embodiment of 
the present invention. The image shows captured red (darker) 65 
and green (lighter) 3T3 cells. The cells were loaded sequen-
tially as described in FIG. 2.  
6 
FIG. 4 schematically depicts an embodiment of a device of 
this invention; a) a weir structure containing capture cups and 
support pillars to keep the weir from sagging to the surface. In 
addition to the drawing, capture cups can be V-shaped or 
square; b) a structure without supports posts; c) a geometry in 
which the flow-through gap is a vertical gap as opposed to the 
horizontal gap shown in (a); d) this geometry uses small posts 
to outline the chambers. 
FIG. 5 illustrates embodiments of a microfluidic device for 
cell capture and pairing. (a) Schematic of the microfluidic 
device operation and structure. The flow passes under the cell 
trap, directing the cells into the capture cup. The support 
pillars maintain the proper vertical gap. (b) The 2x2 mm array 
is in a 1.8-cm-long channel and contains —750-1,200 traps; 
the 8x4 mm array is in a 2.5-cm-long device and contains 
—6,000 traps; and the 1-mm-widex0.5-mm-long array (used 
primarily for optimization of trap geometry and fusion volt-
ages) is in a 1.8-cm-long device array and contains —100 traps 
per channel. Scale bar is 1 cm in (b). 
FIG. 6 is a Time course of chemical- and electric field-
induced fusion for different cell pairs. (a) PEG fusion of 
GFP-expressing mESCs and Hoechst-stained mEFs. Phase-
contrast images show the status of membrane reorganization 
and fluorescence overlay images and line-scans through the 
cells (dashed line) demonstrate the exchange of fluorescence 
Immediately before and after PEG addition, fluorescence was 
sequestered and two cell membranes were distinguishable. At 
t=10 min green fluorescence was observed inside the mEF, 
and at t=15 min the membranes began to reorganize. At t=25 
min hybrids were observed that contained the contents of both 
cells. The mEF nucleus appeared to be intact (no fusion with 
nucleus of mESC). (b) Electrofusion of DsRed- and eGFP-
expressing mouse 3T3s. Immediately after the fusion pulse, 
exchange of fluorescence was observed, outlining the nuclei 
of the cells. At t=10 min the membranes began to reorganize, 
and at t=20 min hybrid cells were observed that contained the 
contents of both cells. (c) Electrofusion of mouse B cells 
expressing GFP and unstained myeloma cells Immediately 
after the fusion pulse, GFP was observed in the properly 
loaded myeloma cell. The third cell in the capture cup was not 
aligned for fusion, therefore no exchange of fluorescence was 
observed and it falls off after t=5 min Membrane reorganiza-
tion was difficult to observe, but at t=20 min only one cell 
membrane was observed. 
FIG. 7 is a Comparison of fusion efficiencies. (a) Compari-
son of PEG fusion efficiency using four doses of PEG and one 
dose of electrofusionin the microfluidic device as determined 
by visual inspection of the data. (b) Comparison of fusion 
efficiencies using the microfluidic device and controls. The 
values are based on red-green doubly fluorescent cells across 
the entire population or device. Control values were deter-
mined by FACS, and device values were determined by visual 
inspection and our image analysis program. The fusion values 
determined from the image analysis program agreed within 
error to those determined through manual inspection *P<0.05 
(two-sided t-test). Error bars, s.d. (n=3). 
FIG. 8 demonstrates functionality of fused cells. (a,b); 
Phase-contrast (a) and fluorescence image (b) of DsRed-
eGFP 3T3s at day 4 after fusion in the microfluidic device 
indicating the presence of red-green double-positive fused 
cells. (c,d) Analyzing only the properly paired red and green 
cells allowed a direct comparison of chemical versus electri-
cal fusion independent of capture and pairing efficiency. 
Scale bars, 100 µm. 
DETAILED DESCRIPTION OF THE INVENTION 
In the following detailed description, numerous specific 
details are set forth in order to provide a thorough understand- 
US 9,201,060 B2 
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ing of the invention. However, it will be understood by those 
skilled in the art that the present invention may be practiced 
without these specific details. In other instances, well-known 
methods, procedures, and components have not been 
described in detail so as not to obscure the present invention. 5 
This invention provides, in some embodiments, microflu-
idic capturing devices and methods of use thereof. 
I. Particle Capture Devices of the Invention 
The invention provides, in one embodiment, a capture-and-
pair microfluidic device comprising a first substrate, at least 10 
one capture unit positioned such that the top of the capture 
unit is adhered to or contiguous with the first substrate. 
The capture unit comprises: a first chamber comprising at 
least one opening, sized to trap and accommodate a single 
particle; and a second chamber comprising at least one open- 15 
ing, sized to trap and accommodate a single or more than a 
single particle; wherein an opening of the first chamber faces 
a direction opposite to that of an opening of the second cham-
ber. The opening of the first chamber is contiguous with a side 
of the capture unit and the opening of the second chamber is 20 
contiguous with an opposite side of the capture unit; option-
ally a second substrate positioned proximally to or adhered to 
a bottom of the capture unit or a portion thereof; a conduit 
through which first flow may be induced in the device, such 
that fluid flow is accommodated at least between the capture 25 
unit and the second substrate and particles positioned within 
the first or second chamber are subject to fluid flow; and 
optionally, a second conduit through which a second flow 
may be induced in a direction opposite to that of the first flow. 
In some embodiments, the device comprises an array of 30 
capture units positioned in rows and/or columns, such that the 
first chamber is in a first row or column and its opening 
opposes that of a second chamber, positioned in a subsequent 
or preceding row or column such that particle transfer from 
one chamber to another may comprise particle movement 35 
from a first row and/or column to another, as desired. 
In some embodiment the term "capture unit' refers to the 
functionality of the unit in trapping or capturing particles in 
the device. In some embodiment the term "capture unit' 
refers to a structure which comprises at least two openings in 40 
which particles may be trapped or captured. In some embodi-
ments, such a capture unit will comprise two chambers, or 
two areas in the unit in which particles may be accommo-
dated, with one chamber accommodating only a single par-
ticle, referred to herein in some embodiments as the "first 45 
chamber" and another accommodating more than the single 
particle, which is referred to herein in some embodiments as 
the "second chamber". In some embodiments, the term cham-
ber refers to a unit which is bounded on all sides, with the 
exception of the indicated opening. In some embodiments, 50 
the term "chamber" refers to a structure, which comprises 
only a single opening large enough to accommodate the indi-
cated particle or particles/size, however it may comprise addi-
tional smaller openings. FIG. 4, for example, provides some 
embodiments of capture units, highlighting the orientation of 55 
components of the chambers of this invention, for example, in 
FIG. 4A or B, the capture unit comprises a bounded chamber, 
with only a single opening. 
In some embodiments, capture units comprise back-to- 
back positioning of first and second chambers. 	 60 
FIG. 4 depicts several embodiments of back-to-backposi-
tioning of chambers in a capture unit. In some embodiments, 
the capture units placed back-to-back, or approximately 
back-to-back, will be in fluid communication, for example as 
depicted in FIG. 4C, where an additional opening is present in 65 
each chamber, where the additional opening is sufficiently 
large to accommodate fluid or other material transfer from  
8 
one chamber to another, however it is not sufficient to permit 
passage of a trapped particle or particles. Similarly in FIG. 
41), a number of openings may be present in each chamber, 
where the additional openings are sufficiently large to accom-
modate fluid or other material transfer from one chamber to 
another, however insufficient to permit passage of a trapped 
particle or particles. 
In some embodiments, the capture unit may comprise two 
chambers spaced distally from each other, or chambers which 
are not bonded together by any material. In some embodi-
ments a capture unit of this invention may comprise two 
chambers, which are not in the same row. In some embodi-
ments a capture unit of this invention may comprise two 
chambers, which are not in the same column. 
In some embodiments the devices will comprise at least 
one supporting structure, which suspends the capture units 
over the second substrate, at a height sufficient to accommo-
date fluid flow at least between the substrate and the capture 
units, such that particles positioned within the first and/or 
second chamber of the capture units are subject to fluid flow. 
In some embodiments, the supporting structure is adhered 
to or contiguous with at least a portion of the capture unit. For 
example, referring to FIG. 4, panel A, wherein the first sub-
strate (4-10) is contiguous with the capture unit (4 -20), which 
is flanked by supporting structures (4 -30). The supporting 
structures extend further than the bounds of the capture unit, 
such that they contact the second substrate (4-40). 
In some embodiments, the device may comprise a support-
ing structure at any location in the device, which serves to 
create a distance between the first and second substrate, or the 
capture unit and the second substrate. For example in FIG. 
413, the supporting pillar is not evident in this scheme; how-
ever a space between the capture unit (4-10) and the second 
structure (4-40) is evident. Such a supporting structure may 
be a single structure positioned anywhere in the device to 
effect such an arrangement. For example, in a rectangular 
device, comprising an array of units, a central supporting 
structure may be sufficient to achieve the desired spacing 
between the first substrate/capture unit and the second sub-
strate. In some embodiments, according to this aspect, sup-
porting structures may be positioned at each corner of the 
device. Other geometries for arrays and devices of the inven-
tion may comprise similarly or comparably positioned sup-
porting structures or a single supporting structure, as will be 
appreciated by the skilled artisan. It is to be understood that 
any positioning of the supporting structure is envisioned, 
which achieves a desired spacing of the first substrate/capture 
unit and the second substrate of the devices of this invention. 
In some embodiments, there is no supporting structure, and 
the first and second substrates are so constructed so as to 
comprise extensions, which achieve the desired spacing as 
herein described. 
In some embodiments capture units of this invention will 
comprise more than a single opening to accommodate fluid 
communication between the trapped particle and fluid flowed 
over the second substrate. In some embodiments, such open-
ings may comprise a slit, or large spacings, or any arrange-
ment which allows fluid flow in the device, and fluid commu-
nication of the particles with the fluid applied to the device, 
such that particles can, in some embodiments, be subject to 
flow. 
In some embodiments, this invention provides apatterning 
device comprising a first substrate onto which capture units 
are constructed, or in some embodiments, the capture units 
are contiguous with the first substrate, or in some embodi-
ments, the capture units are bonded or adhered to the first 
substrate. 
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In one embodiment the first, the second, or both substrates 
are flexible. In one embodiment the first, the second, or both 
substrates are rigid. 
In one embodiment the first, the second, or both substrates 
are flat. In one embodiment the first, the second, or both 
substrates are curved. In one embodiment the substrate is 
curved to a cylindrical shape or a closed tube shape. In one 
embodiment, capture units are patterned on an inner surface 
of a tubed substrate. In one embodiment fluid flows in the 
direction of a long axis of the tubed substrate. According to 
this aspect, and in one embodiment, the capture unit com-
prises chambers positioned back-to-back, such that the top 
and bottom of the capture unit abut the tubed-substrate, such 
that the device comprises only a first substrate. 
In one embodiment the first and the second substrate are 
comprised of the same material. In some embodiments the 
first and the second substrate are comprised of different mate-
rials. 
In one embodiment, a device of this invention may com-
prise parallel-positioned substrates comprising capture units, 
within a single device, such that each substrate is spaced 
sufficiently from one another such that fluid flow applied to 
the device flows over each substrate enabling greater pattern-
ing/capture efficiency in a larger number of capture units per 
volume of the total device. In one embodiment, a flexible 
substrate patterned with capture units is folded to a desired 
shape, for example, in a spiral shape to increase the number of 
capture units per volume of device. In some embodiments 
multiple tubular patterned substrates are packed in parallel in 
a device. It is to be understood that any orientation in the 
device of substrates comprising patterning units, or second 
substrates covering the device may be effected, and such 
devices are to be considered as part of this invention. 
In one embodiment the device may comprise a substrate 
comprising capture units positioned on both sides of the sub-
strate, or on any side of the substrate, or on all sides of the 
substrate. In one embodiment patterning of capture units on 
multiple external sides or internal sides of the substrate 
increases the number of capture units, and in some embodi-
ments, the operating efficiency of the device, or in some 
embodiments, conserves the amount or reagent or particles or 
other materials needed for use in such devices. 
In one embodiment the number of substrates comprising 
capture units within a device of the invention is a factor of the 
dimensions of the device, or in some embodiments, the appli-
cations for use of the device, or in some embodiments, the 
types or dimensions of particles being captured. In some 
embodiments, any number of substrates may be positioned in 
the device, for example, ranging from about 1-10,000. In 
some embodiments, the number of substrates comprising 
capture units per device ranges between 1-10. In one embodi-
ment the number of substrates per device ranges between 
10-100. In one embodiment the number of substrates per 
device ranges between 10-50. In one embodiment the number 
of substrates per device ranges between 100-1000. In one 
embodiment the number of substrates per device ranges 
between 1000-10000. In one embodiment the number of sub-
strates per device ranges between 1000-3000. 
In one embodiment the substrate comprises micro or nano 
wires. In one embodiment the substrate comprises electrical 
conducting micro or nano wires. In one embodiment the 
electrical wiring connects the capture units to contacts at the 
periphery of the substrate. In one embodiment the micro- or 
nano-wires in the substrate are optical fibers. In one embodi-
ment the optical fibers generates or collects optical signals to 
or from the capture unit and their contents. 
10 
Flow is induced in the devices of this invention. In some 
embodiments, flow is induced by the application of a pump, a 
syringe, a piston or a combination thereof. In one embodi-
ment the flow is pressure driven and in another embodiment 
5 the flow is driven by osmosis, orthe flow is an electro-osmotic 
flow. In some embodiments flow is induced by capillary 
forces. In some embodiment the unit to induce flow com-
prises or is connected to adaptors, a power supply, pressure 
gauges, water reservoirs, a vacuum pump, flow controllers, 
io flow timers, sealing accessories, plastic tubing and/or tem-
perature controllers. 
In some embodiments, the devices of this invention com-
prise a conduit through which flow may be induced in the 
device. In some embodiments, the term "conduit' with refer- 
15 ence to inducing flow may refer to an inlet to which a device 
which induces flow is attached, for example a syringe or 
pump, which may be attached directly to the inlet, or in some 
embodiments, via an adaptor, a filter, or any other desired 
material, as will be appreciated by the skilled artisan. In some 
20 embodiments, the conduit is an opening in the device, or in 
some embodiments, the device is sealed around the unit or 
device inducing flow such that a seal between the device and 
the unit inducing flow is accomplished. In some embodiment, 
flow is electroosmotically driven and the conduit refers to the 
25 positioning of electrodes, etc., inducing an electric field in the 
device in order to produce electroosmotic flow in the device 
upon delivery of an electrolyte-containing fluid to the device. 
It is to be understood that any structuring of the device to 
accommodate a unit or means to induce flow in the device is 
30 what is to be understood as encompassed by the phrase "a 
conduit through which fluid may be induced", and is part of 
the present invention. 
In some embodiments flow refers to liquid, solution or fluid 
flow. In one embodiment flow is an air or gas flow, or flow of 
35 an aerosol or gaseous mixture of particles. In one embodi-
ment fluid flow is followed by air/gas flow. In some embodi-
ments subsequent air/gas flow is used to clean, manipulate or 
treat the trapped particles or the device. 
In some embodiments, flow is induced in a single direction, 
4o and the devices of this invention may readily be inverted to 
induce flow in an opposing direction. In some embodiments, 
flow is induced in two directions in the device. 
The capture units are suspended over the second substrate 
in some embodiments. The term "suspended over" refers, in 
45 some embodiments to the orientation of capture units such 
that the chamber openings in the capture units face or oppose, 
respectively the direction of flow induced in the device, and 
these are contiguous with or correspond to the sides of a 
capture unit. The side of the chamber most distal to the open- 
50 ing of the chamber is in some embodiments attached to, or 
proximal to a suspending post, which allows for suspension 
of the capture units. In some embodiments, the side of the 
chamber parallel to and nearest the first substrate surface, is 
the top of the capture unit, whereas the side of the chamber 
55 parallel to and furthest from the first substrate surface is the 
bottom of the capture unit. In some embodiments, the side of 
the chamber most proximal to the second substrate is in some 
embodiments attached to a suspending post, which allows for 
suspension of the capture units. In some embodiments, the 
60 side of the chamber parallel to and nearest the second sub- 
strate surface, is attached or bound to the second substrate by 
suspending posts. In some embodiments two suspending 
posts are attached to the second substrate and to the chambers. 
In some embodiments, the suspending posts may have any 
65 desired shape, and in some embodiments, such choice will 
reflect the type of flow induced in the device, and optimiza- 
tion of flow in the device. In some embodiments the suspend- 




ing posts have a rectangular shape. In some embodiments the 	 cient to accommodate fluid flow at least between the substrate 
two suspending posts have the shape of a rod. In one embodi- 	 and the capture units, such that particles positioned within 
ment the suspending posts are rounded. In one embodiment 	 said first or second chamber are subject to the fluid flow. 
the two suspending posts and the two chambers comprises a 	 In some embodiments two chambers are positioned back to 
capture unit. In some embodiments the two suspending posts 5 back, with openings in or against the direction of fluid flow, 
have spacing therebetween. In some embodiments the spac- 	 wherein an opening of the first chamber faces a direction 
ing allows for flow underneath the chambers and on top of the 	 opposite to that of an opening of the second chamber and 
second substrate. In some embodiments the capture units are 	 wherein the first chamber has a depth which accommodates a 
suspended on supporting pillars such that a gap is formed 	 single particle and the second chamber has a depth which 
between the second substrate and the bottom of the capture io accommodates a single or more than a single particle; 
units to enable fluid flow. In some embodiments the dimen- 	 In some embodiments the two chambers are elevated from 
sions of the supporting pillars are 7 µm widex30 µm deepxS 	 the second substrate surface by two supporting structures 
µm tall. In one embodiment the supporting structure has a 	 patterned in a polydimethylsiloxane (PDMS) substrate. 
width of about 1-15 µm, a length of about 10-50 µm and a 	 In some embodiments the chamber has dimensions on a 
height of about 1-15 µm. In some embodiments the width, 15 micron scale. In some embodiments the first chamber that has 
depth, height or a combination thereof of the supporting 	 a depth which accommodates a single particle is smaller than 
pillars ranges between 10-100 mu. In some embodiments the 	 the second chamber that has a depth which accommodates a 
width, depth, height or a combination thereof of the support- 	 single or more than a single particle. In some embodiments 
ing pillars ranges between 100-1000 nun. In some embodi- 	 the dimensions of the first chamber are 10 µm widex5 µm 
ments the width, depth, height or a combination thereof of the 20 deepx12 µm tall and the dimensions of the second chamber 
supporting pillars ranges between 1-10 µm. In some embodi- 	 are IS M widex25 µm deepx12 µm tall. 
ments the width, depth, height or a combination thereof of the 	 In one embodiment, the first chamber has a width ranging 
supporting pillars ranges between 10-100 µm. In some 	 from between 5-500 µm and a depth ranging from between 
embodiments the width, depth, height or a combination 	 5-500 µm. In one embodiment, the first chamber has a width 
thereof of the supporting pillars ranges between 0.1-100 µm. 25 of about 10 µm and a depth of about 5 µm. In one embodiment, 
In some embodiments the width, depth, height or a combina- 	 the second chamber has a width ranging from between 5-500 
tion thereof of the supporting pillars ranges between 50-100 	 µm and a depth ranging from between 5-500 µm. In one 
µm. 	 embodiment, the second chamber has a width of about 10µm 
In some embodiments the total distance between the first 	 to about 35 µm and a depth of about 5.5 µm to about 50 µm. 
and the second substrates is the sum of the heights of the 30 In some embodiments the width, depth or height or a com- 
capture units and the supporting pillars. In some embodi- 	 bination thereof of the first chambers, the second chambers or 
ments the total distance between the first and the second 	 a combination thereof ranges between 1-10 µm. In one 
substrates is of the order of 1-2 particle diameters. In some 	 embodiment the width, depth or height or a combination 
embodiments the total distance between the first and the 	 thereof of the first chambers, the second chambers or a com- 
second substrates is of the order of 1-5 particle diameters. In 35 bination thereof ranges between 10-100 µm. In one embodi- 
some embodiments the total distance between the first and the 	 ment the width, depth or height or a combination thereof of 
second substrates is 20 microns. In some embodiments the 	 the first chambers, the second chambers or a combination 
total distance between the first and the second substrates 	 thereof ranges between 1-50 µm. In one embodiment the 
ranges between 1-200 microns. In some embodiments the 	 width, depth or height or a combination thereof of the first 
total distance between the first and the second substrates 40 chambers, the second chambers or a combination thereof 
ranges between 1-100 nun. In some embodiments the total 	 ranges between 0.1-10 µm. In one embodiment the width, 
distance between the first and the second substrates ranges 	 depth or height or a combination thereof of the first chambers, 
between 10-1000 mu. In some embodiments the total distance 	 the second chambers or a combination thereof ranges 
between the first and the second substrates ranges between 	 between 0.01-1 µm. In one embodiment the width, depth or 
1-10 µm. In some embodiments the total distance between the 45 height or a combination thereof of the first chambers, the 
first and the second substrates ranges between 10-1000 µm, 	 second chambers or a combination thereof ranges between 
and in other embodiments between 500-1000 µm. 	 0.001-10 µm. In one embodiment the width, depth or height 
In some embodiments, the distance between the first and 	 or a combination thereof of the first chambers, the second 
the second substrates are designed to minimize effects on 	 chambers or a combination thereof ranges between 1-1000 
particles trapped therewithin. In some embodiments, the 50 µm. In one embodiment the width, depth or height or a com- 
chamber orientation and dimension and shape are such to 	 bination thereof of the first chambers, the second chambers or 
minimize impact of the deposition of particles therewithin, in 	 a combination thereof ranges between 10-500 µm. In one 
particular in terms of flow-driven effects. 	 embodiment the difference in size between the first and sec- 
In some embodiments, the device comprises a closed sys- 	 ond chambers is only incremental. In one embodiment the 
tem, having two substrates positioned in parallel, with capture 55 second chamber is only slightly larger than the first chamber. 
units placed therebetween. According to this aspect, and in 	 In one embodiment the depth of the first chamber is 5 microns 
some embodiments, the capture units are attached to supports 	 and the depth of the second chamber is 5.1 micron. In one 
or to suspending posts bound to one of the two substrates, and 	 embodiment the depth of the first chamber is 5 microns and 
flow is induced such that liquid is flowed over the surface of 	 the depth of the second chamber is 5.5 microns. In one 
the second of the two substrates. According to this aspect, and 60 embodiment the width of the first chamber is 10 microns and 
in some embodiments, the capture units are filled with a 	 the width of the second chamber is 10.1 micron. In one 
particle, which is suspended over the second substrate, in the 	 embodiment the width of the first chamber is 10 microns and 
liquid applied to the device and thereby trapped, yet flow is 	 the width of the second chamber is 10.5 microns. In one 
not perturbed by the supports or the suspending posts. 	 embodiment the second chamber accommodates a single par- 
In some embodiments, the suspending posts are an 65 ticle and in another embodiment the second chamber accom- 
example of a supporting structure in the device, which sus- 	 modates more than a single particle. In one embodiment the 
pends the capture units over the substrate, at a height suffi- 	 second chamber accommodates two particles, wherein the 




size of the second particle is I% of the size of the first particle. 
In one embodiment the second chamber accommodates two 
particles, wherein the size of the second particle is 50% of the 
size of the first particle. In one embodiment the second cham-
ber accommodates two particles which are comparable in 
size. 
In one embodiment the chambers are used to trap single 
mammalian cells, and the chamber(s) dimensions for width, 
length, height, etc. ranges from between 10-70 micron. In 
another embodiment the chambers are used to trap single 
bacterial cells and the chamber dimensions for width, length, 
etc., ranges from between 1-10 microns. In one embodiment 
the chambers are used to trap nanoparticles and the chamber 
dimensions for width, length, height, etc. ranges between 1 
mn and 1000 mu. In another embodiment the chambers are 
used to trap large vesicles and the chamber dimensions for 
width, length, height, etc. ranges from between 1-100 
microns. In another embodiment the chambers are used to 
trap small vesicles and the chamber dimensions for width, 
length, height, etc. ranges frombetween 1-100 nm orbetween 
10-1000 mu. 
In some embodiments the chamber has a U-shape. In some 
embodiments the chamber has a triangular shape open on one 
side. In one embodiment the chamber has a square or rectan-
gular shape open on one side. In some embodiments, the 
shape of the chamber may be specific to facilitate trapping of 
the desired cell or particle. For example and in some embodi-
ments, the chambers have round bottom for capturing cells or 
liposomes. For example and in some embodiments, the cham-
bers have a triangular shape to trap rods or cocci. In some 
embodiments the chambers have an opening that is larger in 
dimensions from the bottom of the chambers to facilitate 
transfer of particles from the chamber. In some embodiments 
the chambers have opening that is smaller in dimensions from 
the bottom of the chamber to delay transfer of particles from 
the chamber. In one embodiment facilitating transfer from the 
chamber is desired for first chambers, and delaying transfer 
from a chamber is desired for second chambers. 
In some embodiments the devices of the invention com-
prise an array of capture units. In some embodiments the 
array comprises rows and/or columns. In one embodiment the 
spacing between two capture units in a row and/or column 
and/or the spacing between two rows/columns is comparable 
to about the diameter of one or two particles being captured. 
In one embodiment spacing of the order of a particle diameter, 
enhances the probability of particle capture, while maintain-
ing continuous flow of particles through the device. In one 
embodiment the spacing between two capture units in a row 
and/or the spacing between two rows is 40 microns. In one 
embodiment the spacing between two capture units in a row 
and/or the spacing between two rows ranges between 1-50 
microns. In one embodiment the spacing between two capture 
units in a row and/or the spacing between two rows ranges 
between 50-200 microns. In one embodiment the spacing 
between two capture units in a row and/or the spacing 
between two rows ranges between 0.001-1 microns. In one 
embodiment the spacing between two capture units in a row 
and/or the spacing between two rows ranges between 0.01-10 
microns. 
In some embodiments, device dimensions and capture unit 
positioning within the device will be such that the device is 
easily integrated into existing automated apparatuses, for 
example, within ELISA readers, or other optical-based auto-
mated detection systems. 
In some embodiments there is an off-set between neigh-
boring rows. In some embodiments the off-set is half the 
center-to-center distance between two neighboring units in a 
row. In one embodiment rows are staggered. 
In some embodiments the off-set between neighboring 
rows results in a diagonal placement of any capture unit in 
5 row n with respect to the two closest capture units of row 
(n+l). In some embodiments any capture unit in row n and 
two closest capture units of row (n+l) represent the corners of 
a triangle. In some embodiment the off-set results in having 
capture unit of row n in the same column of capture unit of 
10 
row (n+2). In some embodiments the off-set results in a 
configuration such that the opening of the second chamber of 
row n, faces the opening of the first chamber of row (n+2). In 
some embodiments such configuration allows easy trapping 
15 of particles in the first chamber. In some embodiments such 
configuration enables the direct transfer of particles from a 
first chamber in row (n+2) to a second chamber in row n. In 
some embodiments the configuration allows easy trapping of 
a second particle in a second chamber. In some embodiments 
20 such configuration allows for a smooth fluid flow. In some 
embodiments the direction of the fluid flow can be reversed. 
In some embodiment the fluid flow can enter a first flow 
inducing unit and exit through a second flow inducing unit, 
and in some embodiments the fluid flow can be reversed such 
25 that it enters through the second flow inducing unit and exit 
through the first flow inducing unit. In one embodiment, the 
flow is electro-osmotic, or in another embodiment, the flow is 
pressure driven. In some embodiments fluid can contain par-
ticles or cells and in some embodiment the fluid can be a 
30 particle-free media. 
In some embodiments the capture units, chambers, sup-
porting pillars and spaces between them are scalable to 
nanometers and the particles of interest are nano-sized par-
ticles. 
35 In one embodiment the number of capture units in a device 
is any that is suitable for a particular application. In some 
embodiments, such number will be a reflection of the dimen-
sion of the device and capture units and the scale employed. In 
some embodiments, the number of units ranges from between 
40 1-10. In one embodiment the number of capture units per 
device is ranges from between 1-1000. In one embodiment 
the number of capture units per device ranges from between 
10-100. In one embodiment the number of capture units per 
device ranges from between 100-200. In one embodiment the 
45 number of capture units per device ranges from between 
100-500. In one embodiment the number of capture units per 
device ranges from between 500-1000. In one embodiment 
the number of capture units per device ranges from between 
1000-10000. In one embodiment the number of capture units 
50 per device ranges from between 5000-10000. In one embodi-
ment the number of capture units per device ranges from 
between 200-750. 
In some embodiments, the substrate, chambers, capture 
units, suspension pillars or a combination thereof comprise a 
55 material, which is suitable for any manipulation or condition 
in which particle patterning using the devices of thi s invention 
is desired. In some embodiments, the substrate, chambers, 
capture units, suspension pillars or a combination thereof 
comprise any suitable polymer. 
60 	 In one embodiment the substrate, capture units, suspension 
pillars or a combination thereof comprise an inorganic mate-
rial. In some embodiments the inorganic material is silicon. In 
one embodiment the inorganic material is silicon dioxide or 
silicon nitride or silicon coated by silicon dioxide or silicon 
65 nitride. In one embodiment the inorganic material is titanium 
oxide, indium oxide or indium tin oxide. In one embodiment, 
the inorganic material is a metal or a metal alloy. In one 
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embodiment the inorganic material is gold, Ti/gold, Pt, Pd, or 
gold/palladium. In one embodiment the inorganic material is 
glass, pyrex or quartz. 
In one embodiment the substrate, capture units, suspension 
pillars or a combination thereof are made of a semiconducting 5 
material. In some embodiments the semiconducting material 
is doped. In one embodiment the doping is n-type and in 
another embodiment the doping is p-type. 
In one embodiment the substrate, capture units, suspension 
pillars or a combination thereof are made of a transparent 10 
material. In one embodiment the transparent material is or 
SU-8. 
In one embodiment, the substrate and/or other components 
of the device can be made from a wide variety of materials 
including, but not limited to, silicon, silicon dioxide, silicon 15 
nitride, glass and fused silica, gallium arsenide, indium phos-
phide, III-V materials, PDMS, silicone rubber, aluminum, 
ceramics, polyimide, quartz, plastics, resins and polymers 
including polymethylmethacrylate (PMMA), acrylics, poly-
ethylene, polyethylene terepthalate, polycarbonate, polysty- 20 
rene and other styrene copolymers, polypropylene, polytet-
rafluoroethylene, superalloys, zircalloys, steel, gold, silver, 
copper, tungsten, molybdenum, tantalum, Kovar, Kevlar, 
Kapton, Mylar, Teflon, brass, sapphire, otherplastics, or other 
flexible plastics (polyimide), ceramics, etc., or a combination 25 
thereof. The substrate may be ground or processed flat. High 
quality glasses such as high melting borosilicate or fused 
silicas may be used, in some embodiments, for their UV 
transmission properties when any of the sample manipulation 
and/or detection steps require light based technologies. In 30 
addition, as outlined herein, portions of the internal and/or 
external surfaces of the device may be coated with a variety of 
coatings as needed, to facilitate the manipulation or detection 
technique performed. 
In another embodiment, the substrate and/or chambers of 35 
the devices of this invention comprise a material which is 
functionalized to minimize, reduce or prevent adherence of 
materials introduced into the device. For example, in one 
embodiment, the functionalization comprises coating with 
extracellular matrix protein/s, amino acids, PEG, or PEG 40 
functionalized SAM'S or is slightly charged to prevent adhe-
sion of cells or cellular material to the surface. In another 
embodiment, functionalization comprises treatment of a sur-
face to minimize, reduce or prevent background fluorescence. 
Such functionalization may comprise, for example, inclusion 45 
of anti-quenching materials, as are known in the art. In 
another embodiment, the functionalization may comprise 
treatment with specific materials to alter flow properties of the 
material through the device. In another embodiment, such 
functionalization may be in discrete regions, randomly, or 50 
may entirely functionalize an exposed surface of a device of 
this invention. 
In some embodiments the substrate, capture units, suspen-
sion pillars or a combination thereof are opaque. In one 
embodiment the substrate, capture units, suspension pillars or 55 
a combination thereof are partially transparent, allowing the 
transmittance of parts of the electromagnetic radiation range. 
In some embodiments the transmitted electromagnetic radia-
tion range is in the IR, UV, Visible, Microwave range or a 
combination thereof. 60 
In some embodiments, the substrate, capture units, suspen-
sion pillars or a combination thereof are constructed of a 
material which renders it transparent or semitransparent, in 
order to image the materials being assayed, or in another 
embodiment, to ascertain the progress of the assay, etc. In 65 
some embodiments, the materials further have low conduc-
tivity and high chemical resistance to buffer solutions and/or 
mild organics. In other embodiments, the material is of a 
machinable or moldable polymeric material, and may com-
prise insulators, ceramics, metals or insulator-coated metals. 
In other embodiments, the capture unit/substrate may be con-
structed from a polymer material that is resistant to alkaline 
aqueous solutions and mild organics. In another embodiment, 
the capture unit/substrate comprises at least one surface 
which is transparent or semi-transparent, such that, in one 
embodiment, imaging of the device is possible. 
In one embodiment the substrate, capture units, suspension 
pillars or a combination thereof are coated or covered. In one 
embodiment the coating comprises a monolayer. In one 
embodiment the monolayer comprises organic molecules. In 
one embodiment, the organic molecules comprise a function-
alized end group. 
In one embodiment the organic molecules comprise two 
functional end groups. In one embodiment one functional 
group binds the molecule to the capture unit material and the 
second functional unit is exposed. In one embodiment the 
second functional group is hydrophobic. In one embodiment 
the second functional group is hydrophilic. In one embodi-
ment the exposed functional group prevents cell adhesion, In 
one embodiment the exposed functional group promotes cell 
adhesion. In one embodiment the exposed functional group 
binds cells or particles within chambers. In some embodi-
ments the capture units are coated by an inorganic material. In 
one embodiment the inorganic material is an oxide layer. In 
one embodiment the inorganic material is a metal. In one 
embodiment the coating is gold. In one embodiment the coat-
ing is polar. In one embodiment the coating is non-polar. In 
one embodiment the coating is electrically conducting. In one 
embodiment the coating is electrically insulating or semicon-
ducting. In one embodiment the coating is heat conducting. In 
one embodiment the coating reduces heat transfer. In one 
embodiment the coating of the capture units is achieved by 
exposure to oxygen or other gaseous molecules. In one 
embodiment coating is done by electrodeposition, by electro-
less deposition, by chemical vapor deposition, by sputtering, 
metal evaporation, spin-coating or self-assembly. In one 
embodiment the substrate, capture units, suspension pillars or 
a combination thereof are magnetized to attract metallic par-
ticles. 
In another embodiment, the coating material is a low-
autofluorescent material. In another embodiment, the entire 
array is, and in another embodiment, the array with the excep-
tion of the vessels, is coated with a microstamping material. 
In one embodiment, the microstamping material is polyeth-
ylene glycol or octadecyl-trichlorosilane. In another embodi-
ment, the coating material is a positively charged material. In 
another embodiment, the coating material comprises at least 
one protein, which, in another embodiment, is an extracellu-
lar matrix protein. 
In one embodiment, the substrate, capture units, suspen-
sion pillars or a combination thereof are coated with a mate-
rial, which minimizes particle adhesion thereto, which in one 
embodiment is teflon, or in another embodiments, is a protein 
solution, which in one embodiment, comprises Bovine Serum 
Albumin (BSA). 
In one embodiment, to prevent non-specific cell adsorption 
the substrate, and supporting pillars, or a combination thereof 
but not the inner part of the chambers may be coated, by 
microstamping molecules such as polyethylene glycol (PEG) 
or octadecyl-trichlorosilane (OTS), both of which resist pro-
tein adhesion and are commonly used for confining cells. 
According to this aspect, in some embodiments, because the 
cells will be trapped within chambers, using a blank micros-
tamp to coat the surface will leave the inner part of the 
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chambers uncoated, as desired. In some embodiments, the 
substrate, supporting pillars, chambers or a combination 
thereof may then be flooded with fibronectin or other ECM 
molecules to enhance cell attachment to the inner part of the 
chambers. In some embodiments, the protein-inhibiting sur-
face may also reduce any potential fouling of the device. 
In one embodiment the device has dimensions 1 cm 3 . In 
one embodiment the width, length, and height of the device or 
a combination thereof ranges between 1-10 cm. In one 
embodiment the width, length, and height of the device or a 
combination thereof ranges between 1-10µm. In one embodi-
ment the width, length, and height of the device or a combi-
nation thereof ranges between 10-1000 µm. In one embodi-
ment the width, length, and height of the device or a 
combination thereof ranges between 500-750 µm. In one 
embodiment the width, length, and height of the device or a 
combination thereof ranges between 1-10 cm, or in some 
embodiments, 10-100 mm. In one embodiment the width, 
length, and height of the device or a combination thereof 
ranges between 100-450 µm. In one embodiment the width, 
length, and height of the device or a combination thereof 
ranges between 0.1-1 µm. In one embodiment the width, 
length, and height of the device or a combination thereof 
ranges between 1-10 mu. 
It is to be understood that the devices of this invention may 
be of any dimension suitable for particle trapping and/or 
patterning, to suit any application, and the dimensions 
described serve for exemplification purposes alone. The 
devices of this invention are envisioned for use in micro- and 
nano-fluidic applications, in some embodiments, or for use 
with standard tissue culture dish automated reader applica-
tions. For example in some embodiments, the device may 
approximate 96-well culture plates, or 48 well culture plates, 
or 24 culture plates, with chamber sizes appropriate for cap-
ture of single cells which in turn remain in the device over 
time, where clonal colonies are obtained, for example with 
use in hybridoma technology, or for example for use in stem 
cell engineering applications, for the formation of spheroids 
or other desired structures. 
In one embodiment the devices of this invention are main-
tained under controlled temperature, pH, CO 2 or Oxygen 
conditions, or a combination thereof. 
In one embodiment the device is disposable or in another 
embodiment, sterilizable. 
In one embodiment capture of particles in the devices of 
this invention is achieved with high yield. 
In one embodiment the invention provides capture devices, 
kits comprising the same and methods of use thereof for 
immobilizing two or more particles and for bringing them 
into contact. In some embodiments, a capture unit is used to 
trap and immobilize the particles. In one embodiment the at 
least two particles are trapped consecutively in a capture unit. 
In one embodiment, consecutive trapping of particles enables 
the selection of the particle identity. 
In one embodiment consecutive trapping of particles 
enables sequential particle trapping, such that particles of a 
first type are trapped prior to those of a second type. In one 
embodiment such consecutive trapping enables close contact 
between two different particles. In one embodiment such 
pairing of particles can be useful for synthesis, for particle 
modifications, for cell fusion, for studies of infection, etc. 
In one embodiment pairing of particles is achieved with 
high yield. In one embodiment trapping and pairing of par-
ticles is achieved with high efficiency. In one embodiment 
—80% of the second chambers contain exactly two cells, or 
more, when successive rounds are undertaken to add cells to 
18 
the second chambers, as will be understood by the skilled 
artisan. In one embodiment >50% of the chambers contain 
properly paired cells. 
In some embodiments such consecutive trapping can 
5 involve any number of particles, for example, two or more 
particles. In one embodiment a step-by-step chainprocess can 
be performed on a single particle, or series of particles, using 
the device and methods of the invention. In some embodi-
ments, the first particle is immobilized or attached to a wall of 
io the chamber following transfer to the second chamber, while 
subsequent particles are not adhered, such that sequential 
interaction of subsequent particles with a first particle may be 
effected. 
The devices of this invention, in some embodiments, make 
15 use of a microfabricated array of capture units, which enables, 
in some embodiments, the isolation of two particles in each 
unit. The capture-and-pair process is fast, straightforward and 
inexpensive, and the large array of capture units provides high 
yield of particle pairs, which in the past was difficult to obtain. 
20 Observation and manipulation of the particle pairs is simple 
due to the predetermined positions of the capture units. 
II. Processes to Prepare Capture Devices of the Invention 
In some embodiments the capture units are patterned on the 
substrate. In some embodiments the capture units are pat- 
25 terned using lithography and etching processes. In one 
embodiment lithography is UV, X-ray or electron beam 
lithography. In one embodiment patterning is carried out 
using soft-lithography, stamping, embossing, imprinting or 
patterning using an AFM or an STM tip. In some embodi- 
30 ments device processing involves etching. In one embodi-
ment etching is dry. In one embodiment etching is wet. In one 
embodiment etching is material-selective. In one embodi-
ment a mask is used to protect some areas of the device from 
being etched. In one embodiment the substrate with the cap- 
35 tureunits orthe captureunits alone are patternedusing amold 
or a template. In one embodiment the capture units are glued, 
bonded, soldered or welded to the substrate. In one embodi-
ment coating or layering of the device or of elements in the 
device is carried out by exposure to oxygen or other gaseous 
40 molecules. In one embodiment coating is done by elec-
trodeposition, by electroless deposition, by chemical vapor 
deposition, by sputtering, metal evaporation, spin-coating or 
self-assembly. 
In some embodiments, the devices and methods of this 
45 invention entail patterning a Polydimethylsiloxane (PDMS) 
substrate to form an array of capture units. The patterned 
PDMS substrate serves as the top of the microfluidic channel. 
In some embodiments, the microchannel fabrication is com- 
pleted via e.g. plasma bonding the PDMS patterned first 
50 substrate to a second glass substrate. In some embodiments 
the first patterned substrate is plasma bonded to a second 
silicon or a silicon dioxide substrate. In some embodiment the 
first and second substrates are sealed together by the chemical 
adherence properties between the two substrates. In some 
55 embodiments adherence of the first substrate to glass, poly- 
styrene or to silicon is reversible. In some embodiment one 
type of second substrate can be attached to the first substrate. 
The second substrate can be later removed and replaced by 
another type of second substrate. In one embodiment the first 
6o and second substrates are clamped. In one embodiment 
clamping provides efficient and reversible sealing method for 
the device. In one embodiment an array of patterned sub- 
strates are packed into one device. In one embodiment the 
array is made of parallel planar substrates. In one embodi- 
65 ment the array is made of closely packed cylindrical sub- 
strates. In one embodiment the array is packed using spacers 
between substrates. In one embodiment the spacer are pre- 




patterned into points or areas in the substrate. In one embodi- 	 control system. In one embodiment the temperature control 
ment the spacers are introduced onto the substrate after the 	 system comprises a heating element. In one embodiment the 
substrate is patterned. 	 temperature control system comprises a coolant. In one 
III. Apparatuses/Kits Comprising the Particle Capture and 	 embodiment the coolant comprises a liquid. In one embodi- 
Pair Devices of the Invention 	 5 ment the cooling system is an air-cooling system. In one 
In some embodiments, this invention provides a kit com- 	 embodiment the cooling system comprises a fan. In one 
prising a device of this invention and optionally particles and 	 embodiment the device is wrapped in the temperature control 
reagents for use with the kit. In some embodiments, the 	 system. In one embodiment the temperature control system is 
devices/kits of this invention are modular in design such that 	 built into the substrate and capture units. In some embodi- 
they can be incorporated into larger apparatuses, to which 10 ments the temperature control system is in the form of hollow 
other necessary devices or machineries are coupled. For 	 channels or solid channels carved in or webbed through the 
example, the device comprises inlets/adaptors to which a 	 device. 
flow-generating device may be operationally coupled, or for 	 In one embodiment the apparatuses/devices/kits of this 
example a power source for the application of an electric field 
	
invention comprise/accommodate incorporation of a light 
to the device, etc. 	 15 source, a detector or a combination thereof. In one embodi- 
In one embodiment the modular device is constructed such 	 ment the light source is a UV or visible source. In one embodi- 
that an array of light sources and detectors may readily be 	 ment the light source is in the IR range. In one embodiment 
coupled thereto. In some embodiments the light sources are 	 the light source comprises a lamp. In one embodiment the 
laser sources, visible or UV sources or IR sources. In some 	 light source comprises a laser. In one embodiment the light 
embodiments the array of chambers in the device overlap 20 source is pulsed and in another, continuous. 
with an array of electrical contacts patterned on the device or 	 In one embodiment the apparatuses/devices/kits of this 
proximally or operationally connected to the device, such that 	 invention comprise/accommodate incorporation of a detector 
the contacts supply or detect electrical parameters of the 	 mounted opposite the light source. In one embodiment the 
chamber contents. 	 detector comprises a CCD camera. In one embodiment the 
In some embodiments, electromagnetic radiation excita-  25 detector is further connected to a computer. In one embodi- 
tion of the trapped particles is conducted in conjunction with 	 ment the light source and detector are part of an optical 
electrical excitation or detection. 	 microscope. In one embodiment the detector is a digital cam- 
In one embodiment the modular device is designed such 	 era. In one embodiment the detector is a video camera. 
that it fits onto a microscope moving stage, and individual 
	
According to this aspect and in one embodiment, light 
chambers of the device may be imaged or viewed. In some 30 passes through at least one capture unit and reaches the detec- 
embodiments the microscope stage is automated. In some 	 tor. In one embodiment the detector can read the content of the 
embodiments the contents of the chambers can be observed in 	 capture unit. In one embodiment the detector reads an optical 
a parallel or a serial manner using the automated microscope 	 signal coming from the capture unit and turns it into an image 
stage. In some embodiments, the first or second substrate is of 	 or into a light intensity data. In one embodiment the detector 
a thickness that any desired optical application may be 35 is connected to a processing system. In one embodiment the 
effected, for example, in some embodiments, the device cover 	 detector, computer, processing system, microscope, an opera- 
may be constructed of a coverglass, such that confocal imag- 	 tor or combination thereof can get information regarding the 
ing of the trapped particles is practical. 	 content of the capture unit. In one embodiment a feedback 
In one embodiment the kit comprises a pressure control 	 reaction takes place after optical data is taken and processed. 
gauge. In one embodiment the kit comprises at least one 40 In one embodiment the reaction comprises the introduction of 
syringe. In one embodiment the kit comprises an injection 	 fluid, dispensing fluid, adding chemicals, changing tempera- 
system. In one embodiment the injection system is auto- 	 tures, changing optical or electrical parameters affecting the 
mated. In one embodiment the injection system comprises a 	 contents of the device of this invention. In one embodiment 
robot. In one embodiment the injection system comprises an 	 the detector comprises a fluorescent light detector. In one 
automated pipetor. In one embodiment a series of devices or 45 embodiment the particles trapped in the capture units are 
device arrays of the present invention can be injected with 	 fluorescent or contain fluorescent markers. In one embodi- 
fluids or solutions in a parallel manner. 	 ment the fluorescent marker is fluorescein, a quantum dot or 
In one embodiment, the devices may be coupled to a 	 a green fluorescent protein (GFP). In some embodiments, the 
micropipetor, such that microinjection of trapped cells or 	 labels may include, but are not limited to, fluorescent lan- 
vesicles is readily accomplished. According to this aspect, 50 thanide complexes, including those of Europium and Ter- 
and in some embodiments, such devices may be so con- 	 bium, fluorescamine, rhodamine, tetramethylrhodamine, 
structed so as to effectively trap non-adherent cells for micro- 	 eosin, erythrosin, coumarin, methyl-coumarins, pyrene, Mal- 
injection, which at present is not accomplished with high 	 acite green, stilbene, Lucifer Yellow, Cascade B1ueTM, Texas 
efficiency. In some embodiments, such microinjection meth- 	 Red, 	 1,1'-[1,3-propanediylbis[(dimethylimino-3,l-pro- 
ods offer an advantage in that minimal cell manipulation 55 panediyl]]bis[4-[(3-methyl-2(3H)-benzoxazolylidene)me- 
occurs for microinjection of non-adherent cells in this aspect. 	 thyl]]-,tetraioide, which is sold under the nameYOYO-1, Cy 
In some embodiments, electroporation of trapped indi- 	 and Alexa dyes, and others described in the 9th Edition of the 
vidual cells, or clusters of cells, or colonies of cells may be 	 Molecular Probes Handbook by Richard P. Haugland, hereby 
accomplished, and in one embodiment, transformation effi- 	 expressly incorporated by reference. 
ciency may thus be enhanced by utilizing the devices of the 60 In one embodiment the kit comprises the device or device 
invention. 	 array of this invention further comprises a chemical or a 
In one embodiment the kit comprises of at least one vessel 
	
biological reactor. In one embodiment, before a particle 
to accumulate the solution exiting the device or the device 	 stream enters the device or after particle stream exit the 
array. In one embodiment the vessel is a vial, a test tube, an 	 device, particles undergo a chemical or a biological reaction 
eppendorf, a 96 well array, a petri dish or a sterilized bottle. In 65 in the coupled reactor. In one embodiment prior to passage 
one embodiment the kit comprises a temperature control 	 through the device, the particles are purified, filtered or 
gauge. In one embodiment the kit comprises a temperature 	 rinsed. 




In one embodiment the apparatuses/devices/kits of this 	 IV. Methods of Use of the Particle Capture and Pair 
invention comprise/accommodate incorporation of reagents 	 Devices of the Invention 
to promote adhesion of the cells to specific chambers of the 	 In one embodiment, the invention provides for a method of 
capture units as herein described. In some embodiments, the 	 particle capture and/or pairing, the method comprising apply- 
In one embodiment the apparatuses/devices/kits of this inven-  5 ing liquids comprising the particles of interest to a device of 
tion comprise/accommodate incorporation of reagents to 	 this invention. 
diminish adhesion of the cells to specific chambers of the 	 In one embodiment, this invention provides a method for 
capture units as herein described. In some embodiments, the 	 patterning individual particles, said method comprising: 
apparatuses/devices/kits of this invention comprise/accom- 	 (i) applying a first liquid comprising a series of first particles 
modate incorporation of reagents to dislodge cells whichhave 10 to a particle patterning device under flow in a first direction, 
adhered to a surface of the device, for example, in the cham- 	 whereby an individual particle is accommodated within a first 
ber, or between chambers of the device. Such reagents are 	 chamber in a first capture unit of said particle patterning 
well known in the art, and may comprise, for example, 	 device, said device comprising: 
enzymes or detergents, for example, triton-X, saponin, 	 a first substrate; 
trypsin, and others known in the art. 	 15 	 at least one capture unit positioned such that the top of said 
In some embodiments, the devices of this invention are so 	 capture unit is adhered to or contiguous with said first 
constructed to be of modular design, such that multiple pat- 	 substrate, said capture unit comprising: 
terning devices may be inter-connected to each other, and/or 	 a first chamber comprising at least one opening, sized to 
to other modules, such as those formixing, analysis, imaging, 	 trap and accommodate a single particle; and 
etc., and yet contained within a single housing, in one 20 	 a second chamber comprising at least one opening, sized 
embodiment. In another embodiment, the design construc- 	 to trap and accommodate a single or more than a 
tion is such that numerous arrays can be so constructed, such 	 single particle; 
that any combination of connections may be achieved at a 	 wherein an opening of said first chamber faces a direction 
given time. In some embodiments, a plurality of patterning 	 opposite to that of an opening of said second chamber, 
devices are provided within a single housing along with a 25 	 and said opening of said first chamber is contiguous with 
plurality of sources for inducing flow and means for detection 	 a side of said capture unit, said opening of said second 
and/or analysis. In some embodiments, the individual mod- 	 chamber is contiguous with an opposite side of said 
ules can be replaced without removing or exchanging the 	 capture unit; 
remaining modules. Dovetail rails and other mechanical 	 optionally a second substrate positioned proximally to or 
assemblies facilitate the swapping of modules in and out, in 30 	 adhered to a bottom of said capture unit or a portion 
some embodiments. 	 thereof, 
In some embodiments the invention provides a kit of parts, 	 a conduit through which first flow may be induced in said 
for example a kit comprising the first substrate and capture 	 device, such that fluid flow is accommodated at least 
units. According to this aspect and in some embodiments, the 	 between said capture unit and said second substrate and 
second substrate may be provided separately. In some 35 	 particles positioned within said first or second chamber 
embodiments, the device is constructed so as to be readily 	 are subject to said fluid flow; and 
compatible for use with existing cell analysis or culture mate- 	 optionally, a second conduit through which a second flow 
rials, such as 96 well plates or covers, coverglasses or micro- 	 may be induced in a direction opposite to that of said first 
scope slides, flexible covers, aluminum foil cover, or plastic 	 flow; and 
wraps. In some embodiments a kit comprising two or more 40 (ii) applying a second liquid to said device under flow in a 
substrates with capture units is provided with a means to 	 second direction, wherein said individual particle moves 
attach them together. In some embodiment the substrates 	 from said first chamber of said first capture unit to a second 
containing the capture units are sandwiched together. In some 	 chamber in a second capture unit. 
embodiments, for larger scale capture units, the capture units 	 In one embodiment the method further comprising the step 
are provided unattached to a first substrate so that they can be 45 of applying a third liquid comprising a series of second par- 
subsequently positioned, spread, glued, adhered, bonded, 	 ticles to said device under flow in said second direction, 
pressed between additional substrates or the walls, bottom or 	 whereby the series of second particles are patterned in the 
top of existing kits or units. Such kits or units comprise 	 second chamber in the second capture units with the series of 
microfluidic devices, 96 well plates, cell culture plates, tissue 	 first particles. In one embodiment, there is a contact between 
culture scaffolds or sample holders suitable for a microscope 50 two particles patterned in the same chamber. 
stage, for focused spectroscopy, and for microfluidic devices 	 In one embodiment, the method further comprises the step 
connected to analysis tools, such as cell cytometers, fluores- 	 of applying a third liquid to said device under flow in said first 
cent imaging, chromatography and separation devices, and 
	
direction, whereby said individual particle moves back to said 
chemical analytical instruments such as mass spectra, NMR, 	 first chamber in said first capture unit. 
HPLC, GC, Electroanalytical devices, or surface imaging 55 	 In one embodiment, the liquid comprises a suspension of 
techniques. In some embodiments where a kit of the present 	 particles, or in another embodiment, a cell or tissue homoge- 
invention is supplied without one or two substrates, the sub- 	 nate, or in another embodiment, a culture supernatant, or in 
strates can be later attached using caulking or filler material 	 another embodiment, a culture, or in another embodiment, a 
placed around the sides of the two substrates. The microflu- 	 biological fluid, or any sample with appropriately sized par- 
idic device can be sealed by applying rubber, glue, plastics, 60 ticles whose capture is desired. 
silica sealers to the sides of the two substrates comprising the 	 In one embodiment the liquid is aqueous. In one embodi- 
device. The device, when supplied with a first substrate com- 	 ment the liquid is organic. In one embodiment the suspension 
prises the capture units, contain in some embodiments a wall 	 contains inorganic microparticles or nanoparticles. 
all around the substrate made out of PDMS or compatible 	 In one embodiment, the particles of interest comprise cells, 
materials that will be attached to a second substrate yet leaves 65 including prokaryotic or eukaryotic cells, organelles, viral 
a space between the capture units and the second device to 	 particles, beads, microparticles, vesicles, liposomes, nano- 
accommodate fluid flow. 	 particles or combinations thereof. 




In one embodiment the method further comprises the 	 some embodiment optical manipulation extract a particle pair 
manipulation of the environment of trapped particle 1 /particle 	 from the capture unit. In some embodiment optical manipu- 
2 pairs. 	 lation extracts only particle 2 from the capture unit. 
In one embodiment the manipulation is carried out by 	 In one embodiment the method further comprises electrical 
introducing chemicals through the liquid. In one embodiment 5 manipulation of the particle pair. In one embodiment micro- 
the manipulation involves the introduction of a marker. In one 	 electrodes located within or around or at the vicinity of the 
embodiment manipulation involves chemicals that can 	 large capture unit can generate an electric field. In one 
induce cell fusion. In one embodiment chemicals that can 	 embodiment the electric field can induce membrane perme- 
induce cell fusion are membrane-permeable. In one embodi- 	 ability. In one embodiment said membrane permeability of 
ment the manipulation involves pH change in the liquid. In io cells 1 and cells 2 results in the exchange of intracellular 
some embodiment manipulation involve introduction of salts 	 material between cell I and cell 2. In some embodiments said 
into the liquid. In one embodiment the manipulation involves 	 electrical manipulation causes cell fusion. In some embodi- 
changing the concentrations of salts, or changing the solution. 	 ments electrical manipulation enhances or reduces the adher- 
In one embodiment changing the concentration of solutes in 	 ence of cells to the capture unit. In some embodiments elec- 
the solution changes the osmotic pressure exerted on the cells. 15 trical manipulation alters the functionality of a cell. In some 
In one embodiment a change in the osmotic pressure, rupture 	 embodiment electrical manipulation involves the application 
the cell/vesicle and induce a chemical reaction between two 	 of a voltage on a pair of conducting or semiconducting or a 
cells in contact or between the contents of the cells/vesicles. 	 combination of conducting and semiconducting micropar- 
In one embodiment changing the solution content, causes a 	 ticles. Such application results in measurable changes in con- 
chemical reaction on the surface of the trapped cells or par-  2o ductance, which may be detected by multiple standard means 
ticles. In one embodiment molecules are introduced into the 	 known in the art. 
devices of the invention. In some embodiments the biological 
	
In some embodiments said application of voltage results in 
molecules are proteins, DNA or lipids. In some embodiments 	 light emission. This, as well may be detected by known 
the molecules bind or adhere to the trapped cells/particles. 	 means, for example with the aid of a luminometer. 
In one embodiment manipulation involves changes in tem-  25 	 In some embodiments said application of voltage results in 
perature of the solution. In one embodiment manipulation of 	 an electrical current flow. In one embodiment electrical cur- 
the trapped particles involves binding of a fluorescent mol- 	 rent raises the temperature of the two particles. In some 
ecule to the cells from solution. In one embodiment manipu- 	 embodiments one or more particles reaches their melting 
lating the particles involves exciting a fluorescent molecule 	 point. In some embodiments electrical current cause the 
on or in the particles. In one embodiment the fluorescent so deformation of one or both of the microparticles. In one 
marker is used to track trapping of particles. According to this 	 embodiment said current induces fusion of two micropar- 
aspect, and in one embodiment, the tagged bead is loaded and 	 ticles. In one embodiment said fusion results in a larger single 
its deposition in an array comparable to that of the capture 	 microparticle. In another embodiment fusion results in a 
units confirms trapping of the particles, under flow. In one 	 metal alloyed particle, and in yet another embodiment fusion 
embodiment, a second suspension comprising for example, 35 results in a core-shell particle. In one embodiment the result 
microscopic fluorescent-tagged particles is introduced to a 	 of said fusion and or said melting is a particle assuming the 
device comprising tagged fluorescent beads with different 	 U-shape or any other shape of the chamber. In another 
excitation than that of the particles, and the beads are func- 	 embodiment the result is a spherical particle. In one embodi- 
tionalized to specifically interact with the particles. In some 	 ment the controlled capture of metallic and/or semiconductor 
embodiments, FRET is utilized to determine binding of the 40 particles between microelectrodes is used to construct 
tagged particle with the bead, or colocalization of signals, 	 molecular electronics devices and devices for quantum com- 
etc., or in some embodiments, a reaction creating a particulate 	 puting. 
product may be evaluated by spectrophotometry, or others, as 	 In one embodiment the method further comprises the 
will be appreciated by the skilled artisan. 	 observation of the trapped particle pairs. In one embodiment 
In one embodiment fluorescent markers are used to study 45 such observation involves microscopy. In some embodiments 
the dynamics of particle trapping and reactions or fusion 	 said microscopy is optical. In some embodiments said 
between particles. Similar to the methods described for trap- 	 microscopy is conducted before, during and after particle 
ping above, reactions or fusion between particles may be 	 pairing. In some embodiments said optical microscopy 
accomplished by observing changes in fluorescence, conduc- 	 involves a white light source an in other embodiments a laser 
tance, or other properties known to the skilled artisan, which 50 light source. In one embodiment an optical micrograph of a 
reflect upon the proximal localization or contact between the 	 large part of the array containing many capture units is taken. 
captured particles in a series. 	 In one embodiment a real time movie can be made using said 
In one embodiment manipulation involves the introduction 	 microscopy before, during and after particle capture-and-pair 
of nanoparticles to the solution. In one embodiment the nano- 	 and before-during and after particle manipulation in the cap- 
particles are fluorescent. In some embodiment the nanopar-  55 ture unit. In one embodiment microscopy is electron micros- 
ticles comprises a coating that permits binding of nanopar- 	 copy. In one embodiment microscopy is scanning electron 
ticles to other particles or cells. 	 microscopy (SEM). In one embodiment an SEM image of a 
In one embodiment optical manipulation is carried out on 	 large part of the array containing many capture units is taken. 
the trapped particle or trapped particle pairs. In one embodi- 	 In one embodiment a close-up SEM image shows the result of 
ment optical manipulation causes a chemical reaction involv-  60 particle pair manipulation within one capture unit. In one 
ing the materials of the two or one of the particles. In one 	 embodiment observation is automated and capture units are 
embodiment optical manipulation causes polymerization of 	 observed serially. In one embodiment serial observation is 
material in or at the surface ofparticles 1 or 2 or a combination 	 carried out using microscopy. In one embodiment the device 
thereof. In one embodiment optical manipulation changes the 	 is attached to a computerized moving stage. In one embodi- 
contents or function of the cell. In one embodiment optical 65 ment observation is followed by serial analysis of the capture 
manipulation changes the membrane of the cell. In some 	 units. In one embodiment statistical analysis is carried out for 
embodiment optical manipulation induces cell fusion. In 	 an array of capture units. In one embodiment result of analy- 




sis is part of an algorithm that controls subsequent steps of 	 size ranges between 1-10 µm. In one embodiment the particle 
processing or reaction or analysis. In one embodiment obser- 	 size ranges between 10-100 M. In one embodiment the par- 
vation involves the use of an atomic force microscope (AFM). 	 ticle size ranges between 100-1000 µm. In one embodiment 
In one embodiment the second substrate used for sealing the 	 the particle size ranges between 20-70 µm. 
device is removed and anAFM tip is directed to a capture unit. 5 	 In one embodiment two types of cells are paired by a 
In one embodiment AFM is conducted in solution. In another 	 method of this invention. In one aspect of this embodiment 
embodiment AFM is conducted under ambient conditions or 	 cells type 1 are trapped in the first chamber such that each cell 
in vacuum. In one embodiment AFM is conducted at low 	 is individually trapped in a different chamber. Cells type 1 are 
temperatures. In one embodiment AFM images resolve the 	 transferred into second chambers upon flow reversal and the 
area of contact of the two particles. In one embodiment AFM io introduction of a cell-free liquid. The geometry of the device 
images show a fused particle which is a product of a pair of 
	
in this aspect of the invention, allows only one cell to be 
particles undergoing a process. 	 trapped in each second chamber. Cells type 2 are introduced 
In one embodiment a method of this invention further 	 into the device with a flow direction that permits the trapping 
comprises collecting particles or particle pairs. In one 	 of one cell type 2 in each second chamber already occupied by 
embodiment collecting comprises the extraction of particles 15 one cell type 1. The dimensions of the second chambers are 
from the capture units. In one embodiment extraction 	 designed to fit two cells and therefore any additional cell 
involves the reversal of the flow direction such that a particle 	 trying to enter a two-cell occupied second chamber, will slide 
or a particle pair is extracted from the capture units by the 	 off the filled chamber and continue down the stream line. Two 
flow. In one embodiment the extraction involves the applica- 	 cells are paired in each second chamber and in one embodi- 
tion or removal of an electric field around the capture units 20 ment are held in tight membrane contact. In one embodiment 
holding the particle or particle pairs. In one embodiment said 	 the two cells are held in loose membrane contact. 
extraction involves an optical pulse or the introduction of a 	 In one embodiment a method of this invention comprises a 
chemical from solution in order to extract particles from cells. 	 MEM based device. In this embodiment a capture unit can 
For disposable devices, particle pairs or resulting particles are 	 rotate on an axis perpendicular to the fluid flow. Rotation of 
extracted by dissolving the PDMS matrix in a solvent. Par-  25 the capture unit is achieved using a micro-electro-mechanical 
ticle collection, in one embodiment, comprises the attach- 	 switch incorporated with each capture units. The supporting 
ment of a capture unit to one or two of the input/output ports. 	 pillars are designed such that rotation on the capture units is 
In one embodiment the input/output ports are connected to a 	 enabled. In one embodiment a method for capture-and-pair 
flow cytometer for further analysis. In one embodiment said 
	
based on a MEM device comprises: 
ports are connected to a test tube, a syringe, a vial, or an so 	 i. Orienting the capture units using the electro-mechanical 
additional microfluidic device. In one embodiment the input/ 	 switch such that the first chamber opening faces the fluid 
output ports are connected to a chemical reaction capture unit 	 flow 
for further synthesis or analysis. In some embodiments said 
	
ii. Capture particles type 1 in the first chamber; 
ports are connected to an evaporator for solvent evaporation. 	 iii. Rotating the capture units using the electromechanical 
In some embodiments the particles are collected on a surface. 35 	 switch such that the second chamber opening is now 
In one embodiment said surface is a transmission electron 	 facing the fluid flow. 
microscope grid. 	 iv. Transferring particles type 1 from first chamber to sec- 
In one embodiment the method comprises the capture-and- 	 ond chamber. Transfer is assisted by fluid flow. 
pair of two particles of the same size. In one embodiment the 	 v. Introducing particles type 2 into the solution and captur- 
particles are of different sizes. In one embodiment both par-  40 	 ing particles type 2 in same second chamber already 
ticles are biological cells. In one embodiment one particle is 	 occupied by particles type 1. 
a cell and one particle is a vesicle. In one embodiment one 	 In one embodiment the MEM device is connected to a 
particle is a cell and one particle is a non-biological micro- 	 microscope and an algorithm is used for an automated pro- 
particle. In one embodiment the two particles are vesicles 	 cess. In one embodiment the computerized microscope 
(liposomes). In one embodiment one particle is a liposome 45 counts the number of filled capture units in step ii, and when 
and one particle is a non-biological microparticle. In one 	 the number exceeds a threshold, the MEM switch is activated 
embodiment the two particles are non-biological. In one 	 to start step iii. In one embodiment the computerized imaging 
embodiment at least one particle is metallic or semiconduc- 	 system counts the particles trapped in the large capture units 
tor, or a salt or an inorganic particle, uncoated or coated by an 	 in step iv, and if the number exceeds a threshold, an automated 
organic layer. In one embodiment at least one particle is a 50 introduction of particles type 2 is activated for step v. 
polymer. In one embodiment a particle material is silica, 	 In one embodiment the invention provides a method for 
glass, polystyrene, gold, CdSe or metal oxide. In one embodi- 	 binding of non-biological particles to biological cells. In one 
ment particles are core-shell particles. In one embodiment the 	 embodiment the method comprises the steps of: 
core material is one and the shell material is another. In one 	 vi. capturing a biological cell in a large chamber; 
embodiment core-shell particles have unique optical absorp-  55 	 vii. capturing a non-biological particle in the same large 
tion and scattering properties. In one embodiment electrical 	 chamber such that non-biological particle is held in tight 
properties of core-shell particles can be controlled. In one 	 contact with the membrane of the biological cell. 
embodiment density of core-shell particles is designed. In one 	 In one embodiment of this method the non-biological par- 
embodiment shell material is chosen such that it will bind 	 ticle chemically binds the biological cell. In one embodiment 
biological or chemical functions. In one embodiment the 60 the non-biological particle is coated with a material that 
particle surface comprises fluorescent markers. In one 	 enhances biological cell binding. In one embodiment the 
embodiment the particle itself is fluorescent. 	 non-biological cell is coated with a fluorescent marker. In one 
In one embodiment the particle size ranges from between 	 embodiment the non-biological particle serves as a curved 
1-10 mu. In one embodiment the particle size ranges between 	 cell-growth surface for the growth of the biological cell. In 
10-100 mu. In one embodiment the particle size ranges 65 one embodiment the non-biological particle serves as a load 
between 100-1000 mu. In one embodiment the particle size 	 or a weight. In one embodiment the non-biological particle is 
ranges between 1-0.1-10 µm. In one embodiment the particle 	 made of a material such that it can be trapped using optical 





tweezers. In one embodiment said optical trapping of the 	 optionally results in some change in the particles trapped/ 
	
particle enable the transfer of the biological cell to desired 
	
deposited within the second chamber. 
	
locations. In one embodiment the non-biological particle is 	 In one embodiment, bringing the first and second series of 
	
made of a material which can be locally heated using a light 	 particles into contact results in a transfer of materials from 
source. 	 5 one particle to another. In one embodiment, the materials 
	
In other embodiments, various applications of the methods 	 comprise a biological material, which in one embodiment is a 
	
of the present invention are possible without deviating from 	 nucleic acid or polypeptide. 
the present invention. 	 In one embodiment, the particle is a cell, and in another 
	
By way of example, the capture-and-pair methods of the 	 embodiment, the method results in genetic transformation of 
present invention allow for high-throughput robotic assaying io said cell. For example, and in one embodiment, the first 
	
systems to directly interface with the devices of the present 	 particle is a mammalian cell and the second particle is a virus, 
	
invention, and to pair particles of interest, and/or to carry out 	 or comprises naked nucleic acid, or a plasmid, or a vector. 
two-particle processes. 	 According to this aspect, and in one embodiment, reagents 
	
In one embodiment, this invention provides a method of 	 may be introduced to facilitate transformation, known in the 
contacting individual particles, said method comprising: 	 15 art, or electroporation may be accomplished, etc. In some 
(i) applying a first liquid comprising a series of first par- 	 embodiments, both particles may comprise bacteria, and the 
	
ticles to a particle patterning device under flow in a first 	 method may comprise a method of bacterial conjugation. In 
	
direction, whereby an individual particle is accommodated 	 some embodiments, phage display may be accomplished 
	
within a first capture unit of said particle patterning device, 	 using such methods, as well. In one embodiment methods of 
said device comprising: 	 20 this invention enhance transduction efficiency. 
a first substrate; 	 In one embodiment, the first or second series of particles or 
	
at least one capture unit positioned such that the top of said 	 a combination thereof are cells, and in one embodiment, the 
	
capture unit is adhered to or contiguous with said first 	 method comprises a method of cell fusion. For example, and 
substrate, said capture unit comprising: 	 in some embodiments, early events in bacterial invasion of a 
a first chamber comprising at least one opening, sized to 25 cell may be observed via the methods described herein. In 
trap and accommodate a single particle; and 	 some embodiments, cell fractions may be applied to methods 
	
a second chamber comprising at least one opening, sized 	 of fusion, whereby for example, a phagosome comprising a 
	
to trap and accommodate a single or more than a 	 pathogen is isolated from infected cells, and applied to a first 
single particle; 	 chamber of a device, with the chamber sized to accommodate, 
wherein an opening of said first chamber faces a direction 30 for example, two organelles ortwo cells, such that subsequent 
	
opposite to that of an opening of said second chamber, 	 application of fractionated vesicles from the infected cells are 
	
and said opening of said first chamber corresponds to a 	 applied as well, under flow. Following this, a second flow in 
	
side of said capture unit, said opening of said second 	 an opposite orientation is applied, removing the contents of 
	
chamber corresponds to an opposite side of said capture 	 the first chambers. Such contents may be allowed to remain 
unit; 	 35 outside a chamber for a period of time and under conditions 
	
optionally a second substrate positioned proximally to or 	 allowing fusion events to occur. According to this aspect, and 
	
adhered to a bottom of said capture unit or a portion 	 in one embodiment, the second chambers are oriented per- 
thereof, 	 pendicularly from the first chambers, and flow is now applied 
	
a conduit through which first flow may be induced in said 
	
in a direction such that the contents of the first chambers are 
device, such that fluid flow is accommodated at least 40 conveyed to the second chambers. Fused vesicles will trans- 
	
between said capture unit and said second substrate and 	 port as a single entity to the second chambers, whereas non- 
	
particles positioned within said first or second chamber 	 fused will remain separate, thus vesicular fusion with phago- 
are subject to said fluid flow; and 	 somes may also be ascertained. 
	
optionally, a second conduit through which a second flow 	 In one embodiment, the method comprises a method of 
maybe induced in a direction opposite to that of said first 45 single cell infection. For example, and in some embodiments, 
flow; and 	 certain bacterial species are difficult to separate to single cell 
(ii) applying flow in a second direction, wherein said indi- 	 preparations, without the use of detergents, sonication, etc., 
	
vidual particle moves from said first chamber of said first 	 which in turn may affect the bacteria. In some embodiments, 
	
capture unit to a second chamber in a second capture unit; and 	 applying a suspension of the bacteria under flow, wherein the 
(iii) applying a second liquid comprising a series of second 50 chambers are so constructed so as to only accommodate 
particles to said device in said second direction, 	 single bacterial cells allows a means to isolate single bacteria 
	
whereby said second particles positioned within said sec- 	 without much bacterial manipulation, and subsequent infec- 
	
ond chamber are brought into contact with said series of 	 tion of for example mammalian cells with the single pathogen 
	
first particles, thereby being a method of contacting 	 may then be accomplished. 
individual particles. 	 55 	 In another embodiment, the method comprises a method of 
	
In one embodiment, step (ii) may comprise applying an 	 phagocytosis. According to this aspect, and in some embodi- 
	
additional liquid in an opposing direction, to move the par- 	 ments, early events in pathogenesis occur within seconds or 
	
ticle from the first chamber to the second chamber. In some 	 fractions thereof of phagocytosis, which may be readily 
	
embodiments, the additional liquid may comprise a reagent, 	 observed using the methods of this invention. In some 
which alters, reacts with orbinds the first series ofparticles. In 60 embodiments, molecular interactions may be probed using 
	
some embodiments, the additional liquid may comprise a 	 the methods of this invention, as well. 
	
solvent alone, or a solution, and in some embodiments, does 	 In one embodiment a method of this invention is applicable 
	
not comprise any particles. In some embodiments, the 	 to reprogramming of somatic cells through fusion with 
	
method further comprises iterative introductions of liquids, 	 embryonic stem cells. In one embodiment a method of this 
including liquids comprising a compound or particle of inter-  65 invention is applicable to the generation of antibodies through 
	
est to the device, which interacts with particles in the second 
	
fusion of lymphocytes and myeloma cells. According to this 
	
chamber or deposits material within the second chamber, and 	 aspect and in one embodiment the method is applicable to 
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hybridoma technology. In one embodiment this method pro-
vides for high yield hybridoma technology. In one embodi-
ment the method provides a tool for comparing fusion events 
in a diverse population of cells. 
In one embodiment the device and methods of this inven- 5 
tion enables fusion of cells. In one embodiment fusion is 
chemical. In one embodiment fusion is initiated by flowing 
polyethylene glycol (PEG) or other chemical fusion agent 
past the cells. In one embodiment the chemical fusion agent is 
subsequently replaced with a media. In one embodiment io 
chemical fusion is performed with commercially available 
fusion buffers. 
In one embodiment fusion is electrical. In one embodiment 
electrofusion is initiated by applying an electric field across 
the capture area. In one embodiment the electric field is 15 
applied by extending wires into reservoirs at either end of the 
device. In one embodiment the electric field is applied by 
plasma bonding the PDMS device to a glass slide with pre-
patterned metal electrodes. In one embodiment each chamber 
is individually electrically addressed. In one embodiment 20 
short pulses are applied to fuse the cells in the presence of a 
fusion buffer, and then the cells are washed in media. In one 
embodiment, the device can interface with commercially 
available electrofusion power supplies. 
In one embodiment the device and methods of this inven- 25 
tion provide advantages over existing methods. In one 
embodiment current fusion protocols bring the cells together 
either through pelleting the cells or by applying anAC field to 
polarize the cells. Though the cell membranes are in contact 
there is no specificity in such methods in how the cells are 30 
paired. As a result, the fusion yield is low and can range 
around —I to 8%. In one embodiment fusion yield refers to the 
number of desired fusions as compared with the background 
of improperly fused and unfused cells. In one embodiment, 
using the device and methods of the present invention, the 35 
majority of the cells are properly paired through the loading 
process, leading to a high fusion efficiency. In one embodi-
ment this allows the entire cell population to be used for 
pooled population assays. 
In one embodiment the device and methods of this inven- 40 
tion provides immobilization of cells during and after fusion 
processes. In one embodiment the cells are paired into a 
regular array and are packed closely together, allowing obser-
vation of thousands of cell pairs under a microscope. During 
the entire fusion process, in one embodiment, the cells remain 45 
immobilized. In one embodiment, membrane reorganization 
and exchange of cell contents can easily be observed for 
thousands of cell pairs in parallel. In one embodiment, the 
cells remain immobilized after the fusion process, and can 
remain immobilized for an indefinite length of time. In one 50 
embodiment this is in contrast to current commercial bulk 
protocols that can deliver large numbers of cells, but does not 
allow observation of the cells during the process. 
In one embodiment this invention provides new fusion 
protocols. In one embodiment, the cells are immobilized in a 55 
microfluidic device of this invention and fusion buffers are 
flowed past them. In one embodiment the environment 
around the cells can be quickly changed. In one embodiment 
the environment around the cells can be quickly in about I 
minute. In one embodiment the environment around the cells 60 
is changed simply by changing the solution at the inlet of the 
device or at the inlet of a reservoir. In one embodiment, as a 
result, chemical and electrical fusion can be combined by 
switching the fusion buffers while the cells remain immobi-
lized and properly paired. In one embodiment multiple doses 65 
of fusion protocols can be applied without losing cell contact, 
increasing the overall fusion efficiencies.  
30 
In one embodiment devices and methods of this invention 
can be optimized for fusion applications. In one embodiment 
the PDMS chambers, capture units, capture unit arrays or a 
combination thereof can be put into devices with many dif-
ferent geometries, such as parallel reaction compartments to 
test different fusion protocols. In one embodiment, one such 
example is an optimization device to determine the best 
fusion potentials. In one embodiment, a device with four 
parallel compartments, each containing an array of capture 
units is plasma bonded to a glass slide with electrodes of 
different gaps. In one embodiment, with the application of 
one voltage, four different electric fields are applied across 
the four different compartments. In one embodiment, the 
number of parallel compartments is flexible. In one embodi-
ment the size of the gaps between the electrodes can be easily 
varied. In one embodiment such flexibility and variability 
allows coarse or fine optimization over numerous parallel 
compartments. 
In one embodiment, the device interfaces with commer-
cially available chemical and electrical fusion technologies. 
In one embodiment the device provides a new method of 
capturing and pairing the cells prior to the application of the 
fusion pulse or the fusion trigger. In one embodiment, the 
process of fusion can be monitored. In one embodiment a 
large number of successfully fused cells can be supplied. In 
one embodiment the device can eliminate the need for days of 
culturing and colony picking to isolate the desired fusion 
events. In one embodiment such elimination reduces both the 
time and consumables required to create a new fusion cell 
line. 
In one embodiment, bringing the first and second series of 
particles into contact results in a measurable energy transfer, 
which in one embodiment is fluorescent resonance energy 
transfer (FRET), as described and as will be appreciated by 
one skilled in the art. 
In another embodiment, the method comprises a screen for 
molecular interactions. As noted herein, the method may 
comprise patterning a first particle or cell in a capture unit, 
allowing a subsequent assay or interaction to proceed, remov-
ing the cell and transferring it to another chamber such that for 
example, it is possible to detect binding or fusion events, 
thereby screening for agents which promote or interfere with 
the same. In another embodiment, removing the cell follow-
ing previous exposure to a reagent or assay may result in 
changes in the cells phenotype or activity, which in turn may 
be measured, and serve as a screen for effects of the agent 
applied thereto in this regard. 
It will be appreciated that any time of reaction or interac-
tion between two particles or two materials adhered to par-
ticles may thus be assayed, screened or ascertained and rep-
resents an embodiment of the invention. Such methods may 
be particularly useful in high-throughput assays and screens, 
for example, in screens for activity of certain agents, such as 
antiviral drugs, assayed for their ability to prevent for 
example, syncitia formation in HIV-infected lymphocytes, or 
many other applications, as will be appreciated by the skilled 
artisan. 
In one embodiment, this invention provides controlling for 
cell contact and pairing in a microfluidic device. In one 
embodiment, the efficiency of different fusion impulses was 
evaluated based on independent measurements of fluores-
cence exchange and membrane reorganization. In one 
embodiment, the efficiency of generating fused cells with our 
device was compared with that using conventional protocols. 
In one embodiment, in devices of the present invention, elec-
trofusion resulted in higher fusion efficiencies than chemical 
fusion likely because of the tight membrane contact between 




cell pairs when fused in the cell trap. Although we observed 
	
in the top inlet reservoir and drawn through the device at 
higher fusion efficiencies with electrofusion, this may change 	 15-50 mms-1 using a syringe pump. 
for cell pairs of widely divergent sizes. As the threshold 
	
PEG Fusion in the Microfluidic Device. 
voltage for generating pores required for electrofusion 	 5x105 cells of each cell type were pelleted and resus- 
depends on cell size, and applying too much voltage across 5 pended in —500 ml of medium. The suspension was filtered 
the membrane can cause cell lysis, two cells of very different 	 through a 35 mm cell strainer (BD Falcon) and loaded into the 
sizes may be difficult to electrofuse successfully. In this case, 	 device as described previously. All solutions and media were 
fusion using PEG may be superior in one embodiment. 	 kept at 37° C. PEG-1500 was put into the inlet reservoir and 
Considering that fusion efficiency depends on both pairing 	 drawn past the cells at 0.4 ld/min for 3-5 min. The cells were 
and initiation of fusion, and electrofusion yields in our device 10 washed with 1:1 PEG:medium for 1 min, then incubated in 
were up to —90% in one embodiment, it is clear that pairing 	 medium for 26 min. At time (t)30 min, the cells were washed 
represents the crucial step for high-yield generation of prop- 	 with trypan blue (10% in PBS; pH 7.4) for 5 min, then with 
erly fused cells. The 70% pairing efficiency that was achieved 	 medium for 5 min. At t-40 min, the second dose of PEG was 
in some embodiments, is a substantial improvement over the 	 applied, and the entire protocol was repeated for a total of 4 
25% pairing efficiency previously reported for biotin-strepta-  15 doses. 
vidin-linked cells. In one embodiment, processes of the 	 Electrofusion in the Microfluidic Device. 
present invention are advantageous as they do not require 	 The electrodes for electrofusion were connected to a power 
cell-surface modification. Also, the 51%±16% fusion effi- 	 supply (Eppendorf) in parallel with a 50 kQ resistor. After cell 
ciency for 3T3s obtained in some embodiments, represents a 	 loading, the device was flushed with hypoosmolar fusion 
fivefold increase over the control and previously reported 20 buffer at 0.4 µl/min for 10 min. The cells were pulsed at 
microfluidic fusion yields. 	 varying voltages (0.5 to 2.0 kV cm- ') for 50 µsx5 pulses. 
In one embodiment, cytoplasmic exchange for thousands 	 Hypoosmolar fusion buffer was flushed past the cells for an 
of fusion events in parallel was analyzed, and a slower mode 	 additional 10 min before being replaced with warm medium. 
of membrane reorganization was observed in cells labeled 
	
The cells were then incubated for an additional 15 min at 37° 
with CellTracker dyes. For example, 25 min after fusion 25 C. 
initiation, 24% of CellTracker-labeled 3T3 fibroblasts had 
	
Image Acquisition and Analysis. 
reorganized membranes versus 91% of eGFP-DsRed-ex- 	 The microfluidic device was placed on an automated 
pressing 3T3 fibroblasts according to one embodiment. Close 	 inverted microscope (Zeiss Axiovert 200 m) fitted with a 
inspection indicated that for many CellTracker-labeled cells 	 stage incubator (In vivo Scientific) and images were acquired 
the fluorescence was still somewhat partitioned, and the 30 either every 2.5 min or 5 min. A single randomly chosen 
membrane reorganization, though initiated, was not com- 	 image field (-200-300 capture combs) was used for each 
pleted within the same time frame as for as eGFP-DsRed- 	 experiment, and the size of the image field remained constant. 
expressing cells. 	 Images were analyzed in Image) (US National Institutes of 
In one embodiment, devices of this invention provided 
	
Health) to determine pairing efficiencies (number of traps in 
insight into the fusion process, allowing to decouple fluores-  35 the field of view occupied with a single cell of one type in the 
cence exchange and membrane reorganization and to com- 	 bottom of the well with a second cell (or more) of the other 
pare PEG and electric fusion. In one embodiment, devices of 	 type on top) and fusion efficiencies (based on fluorescence 
this invention can be used for on-chip analysis of a variety of 	 exchange or membrane reorganization). Fluorescence 
fusion-based studies between two-color, one-color and even 	 exchange efficiencies were also analyzed using an automated 
unstained cells. Cells fused in devices of the present invention 40 macro written in ImageJ. 
maintained their viability and morphology off-chip. When 
mEFs were fused to mESCs in a microfluidic device of this 	 Example 1 
invention and plated into a tissue culture dish, reprogramming 
of mEFs was observed. Because devices of this invention can 	 An Embodiment of a Capture-Comb Device of this 
maintain cell registration and analysis in the array, its use to 45 	 Invention 
characterize fusion-mediated reprogramming of somatic 
cells is anticipated in one embodiment. 	 An embodiment of a device of this invention, comprising a 
Various modes of carrying out the invention are contem- 	 two-cell Capture and pair device was fabricated as part of a 
plated as being within the scope of the following claims 	 microfluidic system (FIG. 1). The capture-and pair device 
particularly pointing out and distinctly claiming the subject 50 comprised a microfluidic chamber with an array of capture 
matter, which is regarded as the invention. 	 units, each capture unit holding two chambers. The two 
chambers were positioned back to back within each capture 
EXAMPLES 	 unit. The opening of the two chambers were oriented in and 
against the direction of a fluid flow, respectively (see FIGS.1 
Methods 	 55 and 2). The two chambers in each capture unit differed in size. 
The elements of an embodiment of this device are sche- 
Microfluidic Device Fabrication and Setup. 	 matically depicted in FIG. 2. According to this aspect, 2 
Masters for the microfluidic device were made from SUS 	 chambers (2-20; 2-30) are so positioned within the capture 
(MicroChem) spun on silicon wafers using standard photo- 	 unit (2-10) such that openings of each chamber faces oppos- 
lithographic techniques. PDMS was poured over the master 60 ing directions. The first chamber has a smaller depth (2-20), 
and then degassed before curing. Glass slides with electrodes 	 while on an opposite face of the unit, the second chamber 
were constructed from mask blanks precoated with chrome 	 having a larger depth is positioned (2 -30). The depths are 
and photoresist (Telic), patterned by a transparency mask 	 constructed to accommodate capturing a desired material, for 
exposed to UV light. The PDMS devices and glass slides were 	 example, a single cell (2-40) is accommodated in the first, 
assembled using plasma bonding. The devices were blocked 65 smaller depth chamber, whereas 2 or more cells may be 
with 7.5% bovine serum albumin and rinsed with phosphate- 	 accommodated in the second, larger chamber, within a cap- 
buffered saline (PBS) before use. Cells were manually placed 	 ture unit. The first chamber, in this embodiment, has the 
US 9,201,060 B2 
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dimensions of a single cell (e.g. 10 µm widex5 µm deepxl2 
µm tall) while the second chamber has a depth that accom-
modates two cells (18 µm widex25 µm deepx12 µm tall). Two 
input/output ports are connected to the array on opposite 
sides. Fluid flow (dotted arrows) is in a direction such that 
cells introduced in the device under flow are trapped within 
the first chambers of the capture units of the device, as a 
function of the flow being in the direction of the opening to the 
first chambers and opposite in direction to the opening of the 
second chambers. 
According to this aspect and in one embodiment, a first 
type of cells are flowed into the device, wherein the flow 
direction is toward that of the opening of the first chamber 
with a smaller depth (panel A). Cells which are not captured 
therein are flowed out of the device, thus enabling single cell 
capture. The unit is so designed, such that the array of capture 
units is suspended on posts, such that cells trapped within 
capture units are still influenced by flow conditions. A second 
flow is applied in the opposite direction as that initially 
applied, and single trapped cells are now flowed out of the 
first, smaller chambers (FIG. 213). The design of the device is 
such that a capture chamber having a larger depth has an 
opening which faces the direction of the second flow, such 
that the cells flowed from the smaller capture chambers are 
now delivered to the larger capture chambers (FIG. 2C). Any 
number of materials can be introduced under flow in this 
direction (FIG. 2C), to load additional materials in the cham-
ber of larger dimensions (blue circles). For example, addi-
tional cells or particles, or particulate material may be loaded 
and deposited in the larger capture chamber, with a myriad of 
applications, as will be appreciated by one skilled in the art. 
As a result, in this embodiment, the capture chamber of 
larger dimensions, will comprise a single cell (2-40) and a 
second deposited single cell or particle (2-50), held in tight 
membrane contact. Manipulation of the deposited material 
may be conducted, for example, by assay, electrical manipu-
lation or optical techniques. 
Since the capture-comb device is constructed of transpar-
ent material (Polydimethylsiloxane), the deposited material, 
e.g., cells, can be observed under a microscope. 
In some embodiments, cell-to-cell fusion and exchange of 
intracellular material may be effected, and material deposited 
in the capture unit of larger dimensions may be released from 
the traps by reversing the direction of the flow. 
Example 2 
Capture and Pair of Two Different Cell Types 
FIG. 2 (right panel) and FIG. 3 are fluorescent overlay 
images. Cells were applied to the device and captured in the 
chambers as described in Example 1, representing an embodi-
ment of a method of the present invention. Red and green NIH 
3T3 cells were loaded sequentially as described above. Cells 
were labeled with CellTracker® green and orange. In some 
embodiments 3T3 s were used with stably-integrated GFP and 
REP. In some embodiments GFP-positive mouse embryonic 
stem cells and Hoechst-stained mouse embryonic fibroblasts 
were used. In other embodiments, GFP-positive mouse 
B-cells and unstained myeloma cells were used. 
Cells of a first type (green) were loaded in a direction where 
fluid flow was in a direction opposite to the openings of the 
first chambers in the capture device, thus cells were trapped in 
the first, smaller chambers. Fluid flow direction was then 
reversed such that the trapped cells within the first chamber 
were then flowed to opposing, second, larger chambers in the 
capture device. A second cell type was introduced in the 
34 
device, in the reverse flow orientation such that cells of the 
second type entered the second capture units and joined cells 
type 1 that were already trapped in it. 
5 	 Example 3 
Two-cell Capture-Comb Device for Attaching 
Fluorescent Tags to Cells 
An Embodiment of Use of the Two-Cell 
Capture-Comb Device for Cell Transformation 
Using Stem Cells 
50 	 The fabrication of a two-cell Capture-comb device is 
accomplished as described in Example 1. A mixture of a first 
stem cells type is loaded into the device and transferred into 
the larger capture chambers using the technique described in 
Example 1. Adult (somatic) cells are loaded and trapped in the 
55 large capture chambers, as described, thus adult cells and 
stem cells are paired in each chamber of the capture unit in 
tight membrane contact. Chemical or physical manipulation 
may cause the adult cells to de-differentiate back to an embry-
onic state, thus providing an environment for early tissue 
60 regeneration. 
Example 6 
MEM-based Two-cell Capture-Comb Device 
65 
A two-cell Capture-comb device is described wherein the 
chamber can rotate by applying an electrical force. The rota- 
A two-cell Capture-comb device as described in Example 
l0 I is fabricated. A mixture of cells of a first type is loaded in the 
device and cells are transferred to capture units of larger 
dimensions as described in Example 1. Fluorescent beads or 
quantum dots are introduced into the device as described in 
FIG. 1C, whereby the beads or dots are introduced to the 
15 capture units of larger dimensions comprising the initially 
loaded cells. The dimensions of the capture units are con-
structed such that each capture unit can only hold one cell and 
one bead or quantum dot. The beads or quantum dots, in some 
embodiments, are functionalized, so that they specifically 
20 interact with the cells. Upon release of the cells from the 
device by reversing fluid flow, as described, released cells are 
conjugated to the beads or quantum dots. 
Example 4 
25 
Two-cell Capture-Comb Device for Microsynthesis 
A two-cell capture-comb device is constructed as 
described in Example 1. A mixture of vesicles of a first type is 
loaded in the device and transferred to the capture chambers 
30 of larger dimensions as described in Example 1. Each vesicle 
encapsulates a reagent or reagents. Vesicles of a second type 
are loaded, as well. The vesicles of the second type encapsu-
late a second reagent or reagents. Loading of the two types of 
vesicles, results in localization of both vesicle types in the 
35 large capture chamber, each encapsulating one or more 
reagents. Chemical, optical or electrical manipulation may be 
conducted, such that vesicular fusion occurs, and the intra-
vesicular reagents from both vesicles are mixed. In some 
embodiments, mixing of the reagents from the two vesicles 
40 inside the new fused larger vesicle enables a chemical reac-
tion. Upon release of the fused vesicles using reverse flow, a 
chemical product may be obtained, which is protected within 
the formed fused vesicle. 
45 	
Example 5 
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tion of the capture unit flips the first and second capture 
chambers 180 degrees with respect to their original orienta-
tion. After cells are loaded, flipping of the chamber eliminates 
the need to change flow direction, which in some embodi-
ments is a time-saving advantage. After chamber flipping, 
initially loaded cells or particles are transferred by to the 
second, larger capture chambers. Additional cells and/or par-
ticles may be introduced to the second, larger chamber, by 
introduction through the appropriate port. 
Example 7 
Exchanging Intracellular Material Using 
Electroporation 
A two-cell Capture-comb device is constructed as 
described in Example 1, with the addition of equipping each 
unit with two microelectrodes. Once the desired number of 
cells or vesicles are trapped in the appropriate capture unit, an 
electric field is applied, which causes an increase in penne-
ability of the cell or vesicular membranes. This permeability 
results in an exchange of intracellular material between the 
two cells, allows for introduction of genetic material, for 
example, or any desired substance, such as a drug or a 
molecular probe. Upon removal of the electric field, the tran-
sient cell membrane permeability declines. 
Example 8 
Controlled Release of Modified Cells Using 
Dielectrophoresis 
A two-cell Capture-comb device is constructed as 
described in Example 1 and as described in Example 7. The 
microelectrodes leading to a capture unit can be individually 
addressed [for example as described in A Scalable Addres-
sable Positive-Dielectrophoretic Cell-Sorting Array" Brian 
M. Taff and Joel Uoldman, Anal. Chem. 2005,77,7976-7983, 
incorporated fully herein by reference]. Once two cells are 
trapped, and the desired interaction between the cells accom-
plished, application or removal of an electric field for a spe-
cific capture unit causes release of the cell pair or of the 
resulting single cell from the capture unit. Fluid flow enables 
the collection of the released cells or particles. 
Example 9 
Microparticle Synthesis 
Particles for use in the capture devices of this invention 
may comprise multiple materials. In some embodiments, par-
ticles comprised of one material are loaded first, according to 
methods described in Example 1, and particles comprised of 
a second material are subsequently loaded. In some embodi-
ments, once the two particles are paired, the environmental 
conditions are changed. Such changes may include tempera-
ture, pH, solvent, solution composition, exchange of liquid 
flow with gas or a gaseous mixture flow, gas pressure etc. The 
changes induce a chemical reaction between the two par-
ticles. Depending upon the size and chemical composition of 
the particles a variety of products are obtained. For a pair of 
metallic particles for example, core-shell particles can be 
made if the temperature is elevated to the melting temperature 
of one particle keeping the other particle in the solid state. 
Under controlled conditions, the melted metal can coat the 
solid particle resulting in a core-shell bimetallic micropar-
ticle. The size of the core and the size of the shell can be 
36 
precisely designed by choosing the original size of the two 
particles, or by choosing the size of the capture unit trap. A 
metal alloy can be similarly formed at a temperature where 
the two metals melt. The two metals will mix, and upon 
5 cooling a metal alloy will be formed. The chemical formula of 
the resulting alloy will be defined by the size of the original 
particles and by the synthesis conditions. The processes men-
tioned in this example can be observed in real time using a 
microscope. The processes mentioned in this example are not 
10 limited to metals and can be performed with any combination 
of materials. 
Example 10 
15 	 Microfluidic Control of Cell Pairing and Fusion 
Microfluidic Device Design 
The cell capture device comprised thousands of polydim-
ethyl siloxane (PDMS) cell traps densely arrayed within a 
20 flow-through channel. Each cell trap consisted of a weir struc-
ture that extends vertically into the channel and contained 
front-side and back-side capture cups (FIGS. la-c and FIGS. 
5a, b). Support pillars placed on either side of the capture cups 
allowed flow into and under the trap. The pillar heights were 
25 tailored to be slightly smaller than the cell diameter so the 
cells were trapped once they entered the capture cup. The 
support pillars also maintained proper channel height across 
the array once the device was bonded to a glass substrate. The 
cell traps were incorporated into three different devices; the 
30 largest was 8 mmx4 mm and contained —6,000 traps (FIG. 
le5b). It was observed that the trap spacing within the array 
was critical for efficient capture without clogging. With opti-
mal column spacing (-1-1.5 cell diameters, —20 µm) and a 
row spacing of 20-50 µm, 70-90% of the cells that entered the 
35 array could be captured. 
Cell Capture and Pairing 
2-cell capture and pairing was accomplished using a three-
step loading protocol. First, single cells were isolated in the 
smaller backside capture cup (FIG. 2(1)). Once the array was 
40 saturated, the cells were transferred directly `down' into the 
opposing larger capture cup (FIG. 2(2)). This transfer was fast 
(<1 s), massively parallel and highly efficient because of the 
laminar flow within the device. Finally, the second cell popu-
lation was loaded and trapped immediately in front of the 
45 previously trapped cells (FIG. 2(3)). The larger front-side cup 
was sized to trap 2 cells, so additional cells traveled through 
the array until it was saturated. The obtained 2-cell capture 
efficiencies were up to —80% (percentage of traps occupied 
by exactly 2 cells of any type) and pairing efficiencies of up to 
50 70% (FIG. 3). 
Higher efficiencies were po ssible in the middle and bottom 
of the array where less penetration of larger cell clumps and 
therefore better single cell transfer occurred. 
Fusion in the Microfluidic Device 
55 	 The compatibility of the device with both chemical and 
electrical fusion protocols was tested. Fusion efficiencies 
were determined for all experiments by imaging and counting 
the number of cells that exchanged fluorescent molecules 
(indicative of initiation of fusion) and/or exhibited plasma 
60 membrane reorganization (indicative of advanced fusion). 
First, the capability of the device to fuse different cell types 
using PEG was explored. PEG was flowed past the cells 
causing them to shrink from the osmotic shock. During this 
time, the cells remained in contact and stationary within the 
65 array, demonstrating that the trap geometry can successfully 
immobilize the cells even though there is a substantial change 
in cell volume. Next, the PEG was washed out with medium, 




causing the cells to swell back to their original size and 	 rescence (maximum 63.9% at t5 min) In addition, the 
initiate fusion. One advantage of the device is that solutions 	 amount of fluorescence exchanged also increased as shown 
can be exchanged rapidly while the cells remain paired and in 	 by the CellTracker-labeled red and green doubly fluorescent 
contact; therefore, additional doses of PEG can be applied to 	 cell populations located closer to the center of the plot. This 
increase fusion efficiencies without losing cell pairing or 5 indicates that connections are established that allow continual 
registration. The effect of multiple PEG doses was deter- 	 exchange and eventual equilibration of cytosolic material. 
mined on either unlabeled or CellTracker-labeled 3T3s paired 
	
Slight decreases in the number of doubly fluorescent cells at 
in the device. A wash with a single dose of PEG yielded 15% 
	
later times were artifacts owing to cells shrinking and moving 
fluorescence exchange over CellTracker-labeled 3T3 pairs 	 out of the range of the analysis area. 
and 8% membrane fusion of unlabeled 3T3s, and subsequent io Comparison of PEG Fusion with Electrofusion 
washes with PEG resulted in up to 35% fluorescence 	 The device allowed direct comparison of the fusion effi- 
exchange over CellTracker Green- and Red-labeled pairs and 	 ciencies of different fusion stimuli. PEG and electrofusion 
25% membrane reorganization of unlabeled 3T3s. Viability 	 efficiencies were compared of properly paired cells deter- 
staining with trypan blue performed on both unlabeled and 	 mined by manually inspecting the images and evaluating the 
labeled cells after fusion indicated an increase in cell death 15 fluorescence exchange or membrane reorganization (FIG. 
with additional washes with PEG, eventually limiting the 	 7a). Using PEG, PEG GFP-expressing mESCs paired with 
effectiveness of subsequent doses. 	 Hoechst-stained mEFs were fused in the device. Using PEG, 
Some devices were adapted to be compatible with electro- 	 fusion of 39%±14% of cell pairs was initiated, whereas elec- 
fusion protocols. To introduce electric fields, the device was 	 trofusion resulted in a significantly higher 78±12% fusion 
plasma-bonded to a glass slide containing metal electrodes 20 pairs (P<0.05). These electrofusion efficiencies were compa- 
(FIG. 5b). Once the cells were paired and immobilized, 	 rable to those obtained when DsRed-expressing and 
hypoosmolar fusion buffer was flowed past the cells, causing 	 enhanced GFP (eGFP)-expressing cells were fused electri- 
the cells to swell. The capture cups used were slightly deeper 	 cally in the device (68±24%, with a single-run high of 91 %), 
to accommodate the cells as they became larger. Again, as 	 and with Celffracker-stained mESCs and mEFs (single-run 
with the PEG protocol, the cells remained immobilized and 25 value of 56%). Cells were also placed in the device and 
paired as they changed size. An added benefit is that the cells 	 cultured for 3 d (3 days) without fusion stimulus; no doubly 
were prealigned and in contact so no alternating current field 
	
fluorescent was observed (DsRed and eGFP) cells, indicating 
was required. Membrane fusion was analyzed after the elec- 	 that negligible fusion occurred in the absence of fusogenic 
trical pulse. It was found that electrofusion was significantly 	 stimuli. 
more efficient than PEG-mediated fusion (P<0.05); a single 30 Comparison to Standard Macroscale Fusion Protocols 
series of pulses yielded 78% fluorescence exchange over 	 The overall efficiencies in generating fused cells with our 
CellTracker-labeled red and green cell pairs and 89% mem- 	 device was compared to those with standard commercial PEG 
brane reorganization of unstained 3T3 cells. 	 and electrofusion instruments and protocols. To compare 
Characterization of Cell Fusion 	 between commercial and chip-based protocols, a common 
Another advantage of our device is the ability to observe 35 fusion metric of fluorescence exchange that could be assessed 
the progression of fusion at the single-cell level. Using PEG, 	 for all protocols and has been used by others was primarily 
we fused PEG GFP-expressing mESCs paired with Hoechst- 	 used. Membrane reorganization for the on-chip PEG experi- 
stained mEFs in the device. Before and immediately after the 	 ments was used. Fluorescence exchange was determined 
PEG application, two distinct membranes were visible and 
	 (percent red-green double-positive cells over the whole cell 
fluorescence was still localized within each cell (FIG. 6). 40 population) either by image-analysis program or by FACS 
After 10 min, we observed green fluorescence within the 	 and membrane reorganization was visually evaluated. Fusing 
mEF, demonstrating that the cytosols of the two cells had 
	
CellTracker-labeled 3T3s using a standard PEG protocol 
connected and fusion initiated. The Hoechst nuclear fluores- 	 yielded 6±4% fused cells, compared with a significantly 
cence was still localized in the mEF, indicating that the 	 higher 25±5% fused cells obtained after 4 doses of PEG in our 
nucleus was intact. After 15 min, the plasma membranes 45 micro-fluidic device (P<0.05; FIG. 7b). When electrofusion 
began to reorganize, leading to a hybrid cell at t=25 min 	 in a commercial system was compared to that in the microf- 
containing the contents of both cells. The Hoechst fluores- 	 luidic device, significantly higher fusion efficiencies were 
cence remained partitioned in the new hybrid cell, suggesting 	 found in the microfluidic device (P<0.05). For Cell Tracker- 
no nuclear fusion had taken place. Electrofusion followed a 	 labeled 3T3s, 11±9% fusion in the commercial Helix cham- 
different time course (FIG. 6b,c). Notably, fluorescence 5o ber (Eppendorf) was obtained as compared to 51±16% 
exchange was detected within seconds after the electric pulse, 	 obtained in the microfluidic device of this invention, whereas 
and inmost cases, the outline of the nucleus was visible as the 	 for fluorescent protein-expressing 3T3s, 4±2% fused cells 
fluorescence first moved into the cytoplasm. This exchange of 	 were obtained in the commercial electrofusion system and 
fluorescence was clear even though the cell membranes had 
	
40±13% in the microfluidic device. Finally, 11±4% electro- 
yet to reorganize. After 10 min, the plasma membranes began 55 fusion of CellTracker-labeled mESCs and mEFs was 
to reorganize, and after 20 min, we observed hybrid cells. By 	 obtained in the commercial system, and 23% electrofusion 
immobilizing the cells, we could distinguish exchange of cell 	 with the microfluidic device (single run). In all cases, use of 
contents from membrane reorganization for single cell pairs. 	 the microfluidic device delivered a two-fold to tenfold 
Quantification of Fusion Over the Array 	 improvement in fusion yield compared to commercial sys- 
Immobilizing the cells in a dense array also provides the 60 terns. 
opportunity to observe fusion for thousands of cell pairs in 	 Demonstration of Functionality of Fused Cells 
parallel. Computational image analysis was used to monitor 	 Next, to determine whether cells removed from the chip 
fluorescence exchange over the entire device in a fashion 	 after fusion can survive prolonged culture, 3T3s were 
similar to a fluorescence-activated cell sorting (FACS) plot 	 removed after fusion in the device and cultured for 10 d (10 
Immediately after the electrical pulse, the CellTracker-la-  65 days). Viable fused cells were obtained as determined by the 
beled red and green doubly fluorescent population increased 	 presence of red-green double-positive cells (FIG. 8a,b), and 
to 53.5%. With increasing time, more cells exchanged fluo- 	 via FACS analysis. 





Fusions of embryonic stem cells with somatic cells have 	 3. The particle patterning device of claim 2, wherein said at 
	
been previously used to demonstrate the capability of embry- 	 least one supporting structure is proximal to or contiguous 
	
onic stem cells to reprogram somatic cells. To show that the 	 with at least a portion of said capture unit. 
	
microfluidic device can also be used to generate viable 	 4. The particle patterning device of claim 1, wherein said 
hybrids between mESCs and mEFs, Hygromycin-resistant 5 first chamber, said second chamber, or a combination thereof 
	
mESCs were fused with Puromycin-resistant mEFs in the 	 comprise at least one additional opening, which is sized such 
	
device and cultured under self-renewing conditions. After 14 	 that said opening cannot trap or accommodate one or more 
	
d (14 days) under double selection, drug-resistant colonies 	 particles. 
	
were observed that had an embryonic stem cell-like morphol- 	 5. The particle patterning device of claim 4, wherein said 
ogy and expressed alkaline phosphatase (FIG. 8c). Reactiva-  io additional opening is positioned between said first and second 
	
tion of embryonic genes, such as Nanog and Oct4, has been 	 chamber such that said opening facilitates fluid communica- 
	
used to demonstrate successful reprogramming of somatic 	 tion between said first and said second chamber. 
	
cells. The Puromycin-resistant mEFs carried an additional 
	
6. The particle patterning device of claim 1, further com- 
	
Oct4-GFP reporter in their endogenous Oct4-locus, allowing 	 prising controllers to maintain desirable environmental con- 
to investigate whether reprogramming, as judged by the reac-  15 ditions. 
	
tivation of Oct4-GFP, would also occur. Colonies expressing 	 7. The particle patterning device of claim 6, wherein said 
	
alkaline phosphatase that also expressed GFP were detected, 	 controllers maintain a desired temperature, pH, CO 2 or Oxy- 
	
demonstrating that the device is suitable for generating viable 	 gen conditions, or a combination thereof. 
	
hybrids and observing reprogramming of mEFs after fusion 	 8. The particle patterning device of claim 1, wherein said 
with mESCs (FIG. 8d). 	 20 device is comprised of a transparent material. 
	
While certain features of the invention have been illus- 	 9. The particle patterning device of claim 8, wherein said 
	
trated and described herein, many modifications, substitu- 	 transparent material is pyrex, quartz, Polydimethylsiloxane 
	
tions, changes, and equivalents will now occur to those of 
	 (PDMS) or SU-8. 
	
ordinary skill in the art. It is, therefore, to be understood that 	 10. The particle patterning device of claim 1, further com- 
the appended claims are intended to cover all such modifica-  25 prising electric connections between said first capture unit, 
	
tions and changes as fall within the true spirit of the invention. 	 said second capture unit or a combination thereof and a power 
supply. 
What is claimed is: 	 11. The particle patterning device of claim 1, wherein said 
1. A particle patterning device comprising: 	 device is a microfluidic device. 
a first substrate; 	 30 	 12. The particle patterning device of claim 1, wherein said 
	
at least one capture unit positioned such that the top of said 
	
first chamber has a width ranging from between 5-500 µm and 
	
capture unit is adhered to or contiguous with said first 	 a depth ranging from between 5-500 µm. 
substrate, said capture unit comprising: 	 13. The particle patterning device of claim 12, wherein said 
	
a first chamber comprising at least one opening, sized to 	 first chamber has a width of about 10 µm and a depth of about 
trap and accommodate a single particle; and 	 35 5 µm. 
	
a second chamber comprising at least one opening, sized 
	
14. The particle patterning device of claim 1, wherein said 
	
to trap and accommodate a single or more than a 	 second chamber has a width ranging from between 5-500 µm 
single particle; 	 and a depth ranging from between 5-500 µm. 
wherein an opening of said first chamber faces a direction 15. The particle patterning device of claim 14, wherein said 
opposite to that of an opening of said second chamber, 40 second chamber has a width of about 10 µm to about 35 µm 
and said opening of said first chamber is contiguous with and a depth of about 5.5 µm to about 50 µm. 
	
a side of said capture unit, said opening of said second 
	
16. The particle patterning device of claim 1, comprising 
	
chamber is contiguous with an opposite side of said 	 an array of capture units. 
capture unit; 	 17. The particle patterning device of claim 16, wherein said 
a second substrate positioned proximally to or adhered to a 45 array is arranged in a row or column scheme or a combination 
bottom of said capture unit or a portion thereof, 	 thereof. 
	
a first conduit through which a first flow is induced in said 
	
18. The particle patterning device of claim 17, wherein said 
	
device, such that said first flow is accommodated at least 	 scheme comprises a spacing between said row or column or 
	
between said capture unit and said second substrate and 	 combination thereof, said spacing approximate in width to a 
particles positioned within said first or second chamber 5o diameter of a particle being applied to said device. 
	
are subject to said first flow, wherein said first conduit, 	 19. The particle patterning device of claim 17, wherein said 
	
said capture unit, and said second substrate are config- 	 scheme comprises asymmetrically positioning a capture unit 
	
ured to accommodate said first flow in a direction 	 in a first row off-set from that of a capture unit in a preceding 
towards the opening of the first chamber; and 	 or subsequent row. 
	
a second conduit through which a second flow is induced in 	 55 	 20. The particle patterning device of claim 19, wherein said 
	
a direction opposite to that of said first flow and towards 	 off-set is half the center-to-center distance between two cap- 
	
the opening of the second chamber, such that said second 	 ture units. 
	
flow is accommodated at least between said capture unit 	 21. An apparatus comprising the particle patterning device 
	
and said second substrate and particles positioned within 	 of claim 1. 
	
the first or second chamber are subject to said second 	 60 	 22. The apparatus of claim 21, wherein an illumination 
flow. 	 source is coupled to said device. 
2. The particle patterning device of claim 1, further com- 	 23. The apparatus of claim 22, wherein the illumination 
	
prising at least one supporting structure positioned between 	 source is a laser. 
	
said first and said second substrate, which aids in suspending 	 24. The apparatus of claim 22, wherein a beam splitter is 
said capture unit over said second substrate, at a height suf-  65 employed with the use of said illumination source. 
	
ficient to accommodate fluid flow between said second sub- 	 25. The apparatus of claim 21, further comprising a detec- 
strate and said capture unit. 	 tor, which detects a change in a parameter in said device. 
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26. The apparatus of claim 25, wherein said detector com-
prises a camera, a computer, a luminometer, a spectropho-
tometer, or a combination thereof. 
27. A method for patterning individual particles, said 
method comprising: 
(i) applying a first liquid comprising a series of first par-
ticles to a particle patterning device under flow in a first 
direction, whereby an individual particle is accommo-
dated within a first capture unit of said particle pattern-
ing device, said device comprising: 
a first substrate; 
at least one capture unit positioned such that the top of said 
capture unit is adhered to or contiguous with said first 
substrate, said capture unit comprising: 
a first chamber comprising at least one opening, sized to 
trap and accommodate a single particle; and 
a second chamber comprising at least one opening, sized 
to trap and accommodate a single or more than a 
single particle; 
wherein an opening of said first chamber faces a direction 
opposite to that of an opening of said second chamber, and 
said opening of said first chamber is contiguous with a side of 
said capture unit, said opening of said second chamber is 
contiguous with an opposite side of said capture unit; 
a second substrate positioned proximally to or adhered to a 
bottom of said capture unit or a portion thereof, 
a first conduit through which a first flow is induced in said 
device, such that said first flow is accommodated at least 
between said capture unit and said second substrate and 
particles positioned within said first or second chamber 
are subject to said first flow, wherein said first conduit, 
said capture unit, and said second substrate are config-
ured to accommodate said first flow in a direction 
towards the opening of the first chamber; and 
a second conduit through which a second flow is induced in 
a direction opposite to that of said first flow and towards 
the opening of the second chamber, such that said second 
flow is accommodated at least between said capture unit 
and said second substrate and particles positioned within 
the first or second chamber are subject to said second 
flow; and 
(ii) applying a second liquid to said device under flow in a 
second direction, wherein said individual particle moves 
from said first chamber of said first capture unit to a 
second chamber in a second capture unit. 
28. The method of claim 27, wherein said particle pattern-
ing device comprises an array of capture units positioned in 
rows or columns or a combination thereof. 
29. The method of claim 27, further comprising the step of 
applying a third liquid comprising a series of second particles 
to said device under flow in said second direction, whereby 
said series of second particles are patterned in said second 
chamber in a said second capture units with said series of first 
particles. 
30. The method of claim 27, further comprising the step of 
applying a third liquid to said device under flow in said first 
direction, whereby said individual particle moves back to said 
first chamber in said first capture unit. 
31. The method of claim 29, wherein said series of first 
particles, second particles or a combination thereof are cells, 
vesicles, or microspheres, or a combination thereof. 
32. The method of claim 31, wherein said cells are mam-
malian cells, bacterial cells, parasitic cells, yeast cells or a 
combination thereof. 
42 
33. The method of claim 31, wherein said series of first 
particles and said series of second particles comprise cells of 
a similar cell type or are of, or isolated from, the same organ-
ism. 
5 	 34. The method of claim 31, wherein said series of first 
particles and said series second particles comprise cells of a 
different cell type or are of, or isolated from, a different 
organism. 
35. The method of claim 31, wherein said cells comprise a 
io vector, which optionally comprises a reporter. 
36. The method of claim 31, wherein said method is a 
fusion method between said cells, vesicles, or microspheres, 
or a combination thereof. 
37. The method of claim 27, wherein said method further 
15 comprises applying a reagent to said device under flow in said 
second direction. 
38. The method of claim 37, wherein said reagent is for 
detection, assay or a combination thereof of said series of first 
particles, second particles or a combination thereof. 
20 39. The method of claim 37, wherein said reagent com-
prises a detectable marker. 
40. The method of claim 29, wherein said series of first 
particles and said series of second particles are of the same 
size. 
25 	 41. The method of claim 29, wherein said series of first 
particles and said series of second particles differ in size, 
composition, or a combination thereof. 
42. The method of claim 29, further comprising the step of 
observing said series of first particles and said series of sec-
30 and particles over a course of time. 
43. The method of claim 27, wherein said device is main-
tained under controlled temperature, pH, CO z or Oxygen 
conditions, or a combination thereof. 
44. A method of contacting individual particles, said 
35 method comprising: 
(i) applying a first liquid comprising a series of first par-
ticles to a particle patterning device under flow in a first 
direction, whereby an individual particle is accommo-
dated within a first chamber in a first capture unit of said 
40 	 particle patterning device, said device comprising: 
a first substrate; 
at least one capture unit positioned such that the top of said 
capture unit is adhered to or contiguous with said first 
substrate, said capture unit comprising: 
45 	 a first chamber comprising at least one opening, sized to 
trap and accommodate a single particle; and 
a second chamber comprising at least one opening, sized 
to trap and accommodate a single or more than a 
single particle; 
50 	 wherein an opening of said first chamber faces a direction 
opposite to that of an opening of said second chamber, 
and said opening of said first chamber is contiguous with 
a side of said capture unit, said opening of said second 
chamber is contiguous with an opposite side of said 
55 	 capture unit; 
a second substrate positioned proximally to or adhered to a 
bottom of said capture unit or a portion thereof, 
a first conduit through which a first flow is induced in said 
device, such that first flow is accommodated at least 
60 between said capture unit and said second substrate and 
particles positioned within said first or second chamber 
are subject to said first flow, wherein said first conduit, 
said capture unit, and said second substrate are config-
ured to accommodate said first flow in a direction 
65 towards the opening of the first chamber such that a 
single particle introduced under flow is trapped within 
the first chambers; and 
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a second conduit through which a second flow is induced in 
a direction opposite to that of said first flow and towards 
the opening of the second chamber, such that said second 
flow is accommodated at least between said capture unit 
and said second substrate and particles positioned within 
the first or second chamber are subject to said second 
flow; and 
(ii) applying flow in a second direction, wherein said indi-
vidual particle moves from said first chamber of said first 
capture unit to a second chamber in a second capture 
unit; and 
(iii) applying a second liquid comprising a series of second 
particles to said device in said second direction, 
whereby said second particles positioned within said second 
chamber are brought into contact with said series of first 
particles, thereby being a method of contacting individual 
particles. 
45. The method of claim 44, wherein bringing said first and 
second series of particles into contact results in a transfer of a 
material from one particle to another. 
46. The method of claim 44, wherein said material com-
prise a biological material. 
44 
47. The method of claim 46, wherein said material is a 
nucleic acid or polypeptide. 
48. The method of claim 44, wherein said particle is a cell. 
49. The method of claim 48, wherein said method results in 
5 genetic transformation of said cell. 
50. The method of claim 44, wherein said first or second 
series of particles or a combination thereof are cells. 
51. The method of claim 50, wherein said method com-
prises a method of cell fusion. 
io 52. The method of claim 50, wherein said method com-
prises a method of single cell infection. 
53. The method of claim 50, wherein said method com-
prises a method of phagocytosis. 
54. The method of claim 44, wherein bringing said first and 
is said second series of particles into contact results in a mea-
surable energy transfer. 
55. The method of claim 54, wherein said energy transfer is 
fluorescent resonance energy transfer (FRET). 
56. The method of claim 44, wherein said method com-
prises ses a screen for molecular interactions. 
